Advertisement

Thyroid Pathology

  • Zubair W. Baloch
  • Virginia A. LiVolsi
Chapter
  • 1.2k Downloads

Keywords

Iodide Ghost Bran Sarcoidosis Eosinophilia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Dozois RR, Beahrs OH (1977) Surgical anatomy and technique of thyroid and parathyroid surgery. Surg Clin North Am 57:647–661PubMedGoogle Scholar
  2. 2.
    Akimova RN, Zotikov LA (1969) [An electron microscope study of thyroid gland cells under normal conditions and during the carcinogenic process in golden hamsters]. Vopr Onkol 15:68–75PubMedGoogle Scholar
  3. 3.
    Mansberger AR, Jr., Wei JP (1993) Surgical embryology and anatomy of the thyroid and parathyroid glands. Surg Clin North Am 73:727–746PubMedGoogle Scholar
  4. 4.
    Miller FR (2003) Surgical anatomy of the thyroid and parathyroid glands. Otolaryngol Clin North Am 36:1–7, viiPubMedCrossRefGoogle Scholar
  5. 5.
    Zampi G, Bianchi S, Amorosi A, Vezzosi V (1994) [Thyroid cancer: anatomy and pathologic histology]. Chir Ital 46:4–7PubMedGoogle Scholar
  6. 6.
    Kondalenko VF, Kalinin AP, Odinokova VA (1970) [Ultrastructure of the normal and pathologic human thyroid gland]. Arkh Patol 32:25–34PubMedGoogle Scholar
  7. 7.
    Nesland JM, Sobrinho-Simoes M, Johannessen JV (1987) Scanning electron microscopy of the human thyroid gland and its disorders. Scanning Microsc 1:1797–1810PubMedGoogle Scholar
  8. 8.
    Sugiyama S (1971) The embryology of the human thyroid gland including ultimobranchial body and others related. Ergeb Anat Entwicklungsgesch 44:3–111PubMedGoogle Scholar
  9. 9.
    Kovalenko AE (1999) [Contemporary concepts of embryology and surgical anatomy of the thyroid gland]. Klin Khir 1999:38–42Google Scholar
  10. 10.
    Gibson W, Peng T, Croker B (1980) C-cell nodules in adult human thyroid: a common autopsy finding. Am J Clin Pathol 73:347–351Google Scholar
  11. 11.
    Wolfe H, DeLellis R, Voelkel E, Tashjian A (1975) Distribution of calcitonin containing cells in the normal neonatal human thyroid gland: a correlation of morphology with peptide content. J Clin Endocrinol Metab 41:1076–1081PubMedGoogle Scholar
  12. 12.
    Baschieri L, Castagna M, Fierabracci A, Antonelli A, Del Guerra P, Squartini F (1989) Distribution of calcitonin-and somatostatin-containing cells in thyroid lymphoma and in Hashimoto’s thyroiditis. Appl Pathol 7:99–104PubMedGoogle Scholar
  13. 13.
    Dhillon AP, Rode J, Leathem A, Papadaki L (1982) Somatostatin: a paracrine contribution to hypothyroidism in Hashimoto’s thyroiditis. J Clin Pathol 35:764–770PubMedGoogle Scholar
  14. 14.
    O’Toole K, Fenoglio-Preiser C, Pushparaj N (1985) Endocrine changes associated with the human aging process. III. Effect of age on the number of calcitonin immunoreactive cells in the thyroid gland. Hum Pathol 16:991–1000PubMedGoogle Scholar
  15. 15.
    Guyetant S, Rousselet MC, Durigon M, et al (1997) Sexrelated C cell hyperplasia in the normal human thyroid: a quantitative autopsy study. J Clin Endocrinol Metab 82:42–47PubMedCrossRefGoogle Scholar
  16. 16.
    Harach H (1986) Solid cell nests of the human thyroid in early stages of postnatal life. Acta Anat (Basel) 127:262–264Google Scholar
  17. 17.
    Harach H (1988) Solid cell nests of the thyroid. J Pathol 155:191–200PubMedCrossRefGoogle Scholar
  18. 18.
    Harach HR (1987) Mixed follicles of the human thyroid gland. Acta Anat (Basel) 129:27–30Google Scholar
  19. 19.
    Baloch ZW, LiVolsi VA (1999) Oncocytic lesions of the neuroendocrine system. Semin Diagn Pathol 16:190–199PubMedGoogle Scholar
  20. 20.
    Weiss ML, Deckart H, Pilz R, Deckart E, Kleinau E (1984) [Oncocytes in thyroid gland aspirates. Differential diagnostic problem: tumor/thyroiditis]. Radiobiol Radiother (Berl) 25:765–768Google Scholar
  21. 21.
    Mikhailov IG, Vasil’ev NB, Smirnova EA (1980) [Comparative quantitative electron-microscopic study of the nucleoli of human thyroid oncocytes and follicular cells]. Arkh Patol 42:32–36PubMedGoogle Scholar
  22. 22.
    Mitchell JD, Kirkham N, Machin D (1984) Focal lymphocytic thyroiditis in Southampton. J Pathol 144:269–273PubMedCrossRefGoogle Scholar
  23. 23.
    Kabel PJ, Voorbij HA, van der Gaag RD, Wiersinga WM, de Haan M, Drexhage HA (1987) Dendritic C-cells in autoimmune thyroid disease. Acta Endocrinol Suppl (Copenh) 281:42–48Google Scholar
  24. 24.
    Nakamura Y, Watanabe M, Matsuzuka F, Maruoka H, Miyauchi A, Iwatani Y (2004) Intrathyroidal CD4+ T lymphocytes express high levels of Fas and CD4+ CD8+ macrophages/dendritic C-cells express Fas ligand in autoimmune thyroid disease. Thyroid 14:819–824PubMedGoogle Scholar
  25. 25.
    Katz AD, Hachigian M (1988) Thyroglossal duct cysts. A thirty year experience with emphasis on occurrence in older patients. Am J Surg 155:741–744PubMedCrossRefGoogle Scholar
  26. 26.
    Sturgis EM, Miller RH (1988) Thyroglossal duct cysts. J La State Med Soc 145:459–461Google Scholar
  27. 27.
    Topf P, Fried MP, Strome M (1988) Vagaries of thyroglossal duct cysts. Laryngoscope 98:740–742PubMedCrossRefGoogle Scholar
  28. 28.
    Allard R (1982) The thyroglossal cyst. Head Neck Surg 5:134–140PubMedGoogle Scholar
  29. 29.
    Baughman R (1972) Lingual thyroid and lingual thyroglossal tract remnants. Oral Surg Oral Med Oral Pathol 34:781–798PubMedCrossRefGoogle Scholar
  30. 30.
    Heshmati HM, Fatourechi V, van Heerden JA, Hay ID, Goellner JR (1997) Thyroglossal duct carcinoma: report of 12 cases. Mayo Clin Proc 72:315–319PubMedGoogle Scholar
  31. 31.
    Apel RL, Asa SL, Chalvardjian A, LiVolsi VA (1994) Intrathyroidal lymphoepithelial cysts of probable branchial origin [see comments]. Hum Pathol 25:1238–1242PubMedCrossRefGoogle Scholar
  32. 32.
    Carpenter GR, Emery JL (1976) Inclusions in the human thyroid. J Anat 122:77–89PubMedGoogle Scholar
  33. 33.
    Harach HR, Vujanic GM, Jasani B (1993) Ultimobranchial body nests in human fetal thyroid: an autopsy, histological, and immunohistochemical study in relation to solid cell nests and mucoepidermoid carcinoma of the thyroid. J Pathol 169:465–469PubMedCrossRefGoogle Scholar
  34. 34.
    LiVolsi VA (1990) Surgical pathology of the thyroid. Saunders, PhiladelphiaGoogle Scholar
  35. 35.
    Rosai J, Carcangui ML, DeLellis RA (1992) Tumors of the thyroid gland, vol 3rd series, fascicle 5. Armed Forces Institute of Pathology, Washington, DCGoogle Scholar
  36. 36.
    Hathaway BM (1965) Innocuous accessory thyroid nodules. Arch Surg 90:222–227PubMedGoogle Scholar
  37. 37.
    Baloch Z, LiVolsi VA (2002) Pathology of the thyroid gland. Churchill Livingston, PhiladelphiaGoogle Scholar
  38. 38.
    Gerard-Marchant R (1964) Thyroid follicle inclusions in cervical lymph nodes. Arch Pathol Lab Med 77:637–643Google Scholar
  39. 39.
    Roth L (1065) Inclusions of nonneoplastic thyroid tissue within cervical lymph nodes. Cancer 18:105–111CrossRefGoogle Scholar
  40. 40.
    Meyer J, Steinberg L (1969) Microscopically benign thyroid follicles in cervical lymph nodes. Cancer 24:301–311CrossRefGoogle Scholar
  41. 41.
    Bataskis J, Nishiyama R, Schmidt R (1963) “Sporadic goiter syndrome”: a clinicopathologic analysis. Am J Clin Pathol 30:241–251Google Scholar
  42. 42.
    Johnson J (1949) Adenomatous goiters with and without hyperthyroidism. Arch Surg 59:1088–1099PubMedGoogle Scholar
  43. 43.
    Struder H, Ramelli F (1982) Simple goiter and its variants: euthyroid and hyperthyroid. Endocr Rev 3:40–61Google Scholar
  44. 44.
    Weaver D, Batsakis J, Nishiyama R (1969) Relationship of iodine to “lymphocytic goiter.” Arch Surg 98:183–185PubMedGoogle Scholar
  45. 45.
    Brown R, Jackson I, Pohl S, Reichlin S (1978) Do thyroid stimulating immunoglobulins cause nontoxic and toxic multinodular goiter? Lancet 1:904–906Google Scholar
  46. 46.
    Gaitan E, Nelson NC, Poole GV (1991) Endemic goiter and endemic thyroid disorders. World J Surg 15:205–215PubMedCrossRefGoogle Scholar
  47. 47.
    Braverman LE (2001) The physiology and pathophysiology of iodine and the thyroid. Thyroid 11:405PubMedCrossRefGoogle Scholar
  48. 48.
    Ghossein RA, Rosai J, Heffess C (1997) Dyshormonogenetic goiter: a clinicopathologic study of 56 cases. Endocr Pathol 8:283–292PubMedGoogle Scholar
  49. 49.
    Rosenthal D, Carvalho-Guimaraes DP, Knobel M, Medeiros-Neto GA (1990) Dyshormonogenetic goiter: presence of an inhibitor of normal human thyroid peroxidase. J Endocrinol Invest 13:901–904PubMedGoogle Scholar
  50. 50.
    Bala TS, Janardanasarma MK, Raghunath M (1996) Dietary goitrogen-induced changes in the transport of 2-deoxy-d-glucose and amino acids across the rat blood-brain barrier. Int J Dev Neurosci 14:575–583PubMedGoogle Scholar
  51. 51.
    Fenwick GR, Griffiths NM (1981) The identification of the goitrogen (-)5-vinyloxazolidine-2-thione (goitrin) as a bitter principle of cooked Brussels sprouts (Brassica oleracea L. var. gemmifera). Z Lebensm Unters Forsch 172:90–92PubMedCrossRefGoogle Scholar
  52. 52.
    Gabrilove JL, Dorrance WR, Soffer LJ (1952) Effect of corticotropin, cortisone and desoxycorticosterone on thyroid weight of the goitrogen-treated rat. Am J Physiol 169:565–567PubMedGoogle Scholar
  53. 53.
    Amdisen A, Jensen SE, Olsen T, Schou M (1968) [Development of goiter during lithium treatment]. Ugeskr Laeger 130:1515–1518PubMedGoogle Scholar
  54. 54.
    Maloof F, Wang CA, Vickery AL, Jr (1975) Nontoxic goiter-diffuse or nodular. Med Clin North Am 59:1221–1232PubMedGoogle Scholar
  55. 55.
    Struder H, Peter H, Gerber H (1987) Morphologic and functional changes in developing goiters. In: Hall R, Kobberling J (eds) Thyroid disorders associated with iodine deficiency and excess. Raven, New YorkGoogle Scholar
  56. 56.
    Murray D (1998) The thyroid gland. Blackwell Science, Malden, MAGoogle Scholar
  57. 57.
    Barsano C, DeGroot L (1979) Dyshormonogenetic goiter. Baillieres Clin Endocrinol Metab 8:145–165Google Scholar
  58. 58.
    Medeiros-Neto G, Bunduki V, Tomimori E, et al (1997) Prenatal diagnosis and treatment of dyshormonogenetic fetal goiter due to defective thyroglobulin synthesis. J Clin Endocrinol Metab 82:4239–4242PubMedCrossRefGoogle Scholar
  59. 59.
    Ramelli F, Studer H, Bruggisser D (1982) Pathogenesis of thyroid nodules in multinodular goiter. Am J Pathol 109:215–223PubMedGoogle Scholar
  60. 60.
    Fialho NJ, de Oliveira CA (1971) [Colloid goiter (observations on 100 operated and treated cases)]. Rev Bras Med 28:314–326PubMedGoogle Scholar
  61. 61.
    Greer MA, Studer H, Kendall JW (1967) Studies on the pathogenesis of colloid goiter. Endocrinology 81:623–632PubMedGoogle Scholar
  62. 62.
    Nair K (1951) Adenoma of thyroid: simple adenomatous goiter. Antiseptic 48:716–724PubMedGoogle Scholar
  63. 63.
    Hirosawa H, Noguchi M, Sakata N, Tanaka S, Miyazaki I (1983) [Adenoma or adenomatous goiter with the clinical symptoms of hyperthyroidism]. Horumon To Rinsho 31(suppl):95–98PubMedGoogle Scholar
  64. 64.
    Apel RL, Ezzat S, Bapat BV, Pan N, LiVolsi VA, Asa SL (1995) Clonality of thyroid nodules in sporadic goiter. Diagn Mol Pathol 4:113–121PubMedGoogle Scholar
  65. 65.
    Hicks DG, LiVolsi VA, Neidich JA, Puck JM, Kant JA (1990) Clonal analysis of solitary follicular nodules in the thyroid. Am J Pathol 137:553–562PubMedGoogle Scholar
  66. 66.
    Miller JM (1975) Plummer’s disease. Med Clin North Am 59:1203–1216PubMedGoogle Scholar
  67. 67.
    LiVolsi VA (1994) The pathology of autoimmune thyroid disease: a review. Thyroid 4:333–339PubMedGoogle Scholar
  68. 68.
    Margolick JB, Hsu SM, Volkman DJ, Burman KD, Fauci AS (1984) Immunohistochemical characterization of intrathyroid lymphocytes in Graves’ disease. Interstitial and intraepithelial populations. Am J Med 76:815–821PubMedCrossRefGoogle Scholar
  69. 69.
    Misaki T, Konishi J, Nakashima T, et al (1985) Immunohistological phenotyping of thyroid infiltrating lymphocytes in Graves’ disease and Hashimoto’s thyroiditis. Clin Exp Immunol 60:104–110PubMedGoogle Scholar
  70. 70.
    Totterman TH (1978) Distribution of T-, B-, and thyroglobulin-binding lymphocytes infiltrating the gland in Graves’ disease, Hashimoto’s thyroiditis, and de Quervain’s thyroiditis. Clin Immunol Immunopathol 10:270–277PubMedCrossRefGoogle Scholar
  71. 71.
    Misaki T, Konishi J, Arai K, et al (1987) HLA-DR antigen expression on intrathyroidal lymphocytes and thyrocytes in Hashimoto’s thyroiditis and Graves’ disease: an immunohistological study. Endocrinol Jpn 34:257–262PubMedGoogle Scholar
  72. 72.
    Weetman AP, Gunn C, Hall R, McGregor AM (1985) Thyroid autoantigen-induced lymphocyte proliferation in Graves’ disease and Hashimoto’s thyroiditis. J Clin Lab Immunol 17:1–6PubMedGoogle Scholar
  73. 73.
    Brinkane A, Ounadi-Corbille W, Bellamy J, Leroy-Terquem E (2004) [Hyperplasia of the thymus in Graves’ disease. A case report]. Rev Pneumol Clin 60:239–241PubMedGoogle Scholar
  74. 74.
    Kawai K, Tamai H, Mori T, et al (1993) Thyroid histology of hyperthyroid Graves’ disease with undetectable thyrotropin receptor antibodies. J Clin Endocrinol Metab 77:716–719PubMedCrossRefGoogle Scholar
  75. 75.
    Hirota Y, Tamai H, Hayashi Y, et al (1986) Thyroid function and histology in forty-five patients with hyperthyroid Graves’ disease in clinical remission more than ten years after thionamide drug treatment. J Clin Endocrinol Metab 62:165–169PubMedGoogle Scholar
  76. 76.
    Cassano C (1971) [Dyshormonogenetic goiter caused by altered synthesis of thyroglobulin]. Recenti Prog Med 50:9–23PubMedGoogle Scholar
  77. 77.
    Vickery AL, Jr (1981) The diagnosis of malignancy in dyshormonogenetic goitre. Clin Endocrinol Metab 10:317–335PubMedCrossRefGoogle Scholar
  78. 78.
    Roti E, Uberti ED (2001) Iodine excess and hyperthyroidism. Thyroid 11:493–500PubMedCrossRefGoogle Scholar
  79. 79.
    Strauss A, Trujillo M (1986) Lithium-induced goiter and voice changes. J Clin Psychopharmacol 6:120–121PubMedGoogle Scholar
  80. 80.
    Mizukami Y, Funaki N, Hashimoto T, Kawato M, Michigishi T, Matsubara F (1988) Histologic features of thyroid gland in a patient with bromide-induced hypothyroidism. Am J Clin Pathol 89:802–805PubMedGoogle Scholar
  81. 81.
    Imai C, Kakihara T, Watanabe A, et al (2002) Acute suppurative thyroiditis as a rare complication of aggressive chemotherapy in children with acute myelogenous leukemia. Pediatr Hematol Oncol 19:247–253PubMedCrossRefGoogle Scholar
  82. 82.
    Lambert MJ 3rd, Johns ME, Mentzer R (1980) Acute suppurative thyroiditis. Am Surg 46:461–463PubMedGoogle Scholar
  83. 83.
    Golshan MM, McHenry CR, de Vente J, Kalajyian RC, Hsu RM, Tomashefski JF (1997) Acute suppurative thyroiditis and necrosis of the thyroid gland: a rare endocrine manifestation of acquired immunodeficiency syndrome. Surgery 121:593–596PubMedCrossRefGoogle Scholar
  84. 84.
    Leesen E, Janssen L, Smet M, Breysem L (2001) Acute suppurative thyroiditis. JBR-BTR 84:68PubMedGoogle Scholar
  85. 85.
    Hnilica P, Nyulassy S (1985) Plasma cells in aspirates of goitre and overt permanent hypothyroidism following subacute thyroiditis. Preliminary report. Endocrinol Exp 19:221–226PubMedGoogle Scholar
  86. 86.
    Weetman AP, Smallridge RC, Nutman TB, Burman KD (1987) Persistent thyroid autoimmunity after subacute thyroiditis. J Clin Lab Immunol 23:1–6PubMedGoogle Scholar
  87. 87.
    Greene J. Subacute thyroiditis (1971) Am J Med 51:97–108PubMedCrossRefGoogle Scholar
  88. 88.
    Bastenie P, Bonnyns M, Neve P (1972) Subacute and chronic granulomatous thyroiditis. In: Bastenie PA, Ermans AM (eds) Thyroiditis and thyroid function, clinical, morphological and physicological studies. Pergamon, Oxford, pp 69–97Google Scholar
  89. 89.
    Cordray JP, Nys P, Merceron RE, Augusti A (2001) [Frequency of hypothyroidism after de Quervain thyroiditis and contribution of ultrasonographic thyroid volume measurement]. Ann Med Interne (Paris) 152:84–88Google Scholar
  90. 90.
    Harach HR, Williams ED (1990) The pathology of granulomatous diseases of the thyroid gland. Sarcoidosis 7:19–27PubMedGoogle Scholar
  91. 91.
    Meachim G, Young M (1963) De Quervain’s subacute granulomatous thyroiditis: histological identification and incidence. J Clin Pathol 16:189–199PubMedGoogle Scholar
  92. 92.
    Carney JA, Moore SB, Northcutt RC, Woolner LB, Stillwell GK (1975) Palpation thyroiditis (multifocal granulomatous folliculitis). Am J Clin Pathol 64:639–647PubMedGoogle Scholar
  93. 93.
    Harach HR (1993) Palpation thyroiditis resembling C cell hyperplasia. Usefulness of immunohistochemistry in their differential diagnosis. Pathol Res Pract 189:488–490PubMedGoogle Scholar
  94. 94.
    Mizukami Y, Michigishi T, Kawato M, et al (1982) Chronic thyroiditis: thyroid function and histologic correlations in 601 cases. Hum Pathol 23:980CrossRefGoogle Scholar
  95. 95.
    Hayashi Y, Tamai H, Fukata S, et al (1985) A long term clinical, immunological, and histological follow-up study of patients with goitrous chronic lymphocytic thyroiditis. J Clin Endocrinol Metab 61:1172–1178PubMedGoogle Scholar
  96. 96.
    Roitt IM, De Carvalho LC (1982) The immunological basis of autoimmune disease. Ciba Found Symp 1982:22–34Google Scholar
  97. 97.
    Podleski WK (1971) Quantitative distribution of IgG, IgM and IgA immunoglobulins in lymphocytic thyroiditis of the Hashimoto type. Arch Immunol Ther Exp 19:431–438Google Scholar
  98. 98.
    Tomer Y, Ban Y, Concepcion E, et al (2003) Common and unique susceptibility loci in Graves and Hashimoto diseases: results of whole-genome screening in a data set of 102 multiplex families. Am J Hum Genet 73:736–747PubMedCrossRefGoogle Scholar
  99. 99.
    Fatourechi V, McConahey WM, Woolner LB (1971) Hyperthyroidism associated with histologic Hashimoto’s thyroiditis. Mayo Clin Proc 46:682–689PubMedGoogle Scholar
  100. 100.
    Mizukami Y, Michigishi T, Hashimoto T, et al (1988) Silent thyroiditis: a histologic and immunohistochemical study. Hum Pathol 19:423–431PubMedGoogle Scholar
  101. 101.
    Aozasa M, Amino N, Iwatani Y, et al (1989) Intrathyroidal HLA-DR-positive lymphocytes in Hashimoto’s disease: increases in CD8 and Leu7 cells. Clin Immunol Immunopathol 52:516–522PubMedCrossRefGoogle Scholar
  102. 102.
    Iwatani Y, Amino N, Mori H, et al (1983) T lymphocyte subsets in autoimmune thyroid diseases and subacute thyroiditis detected with monoclonal antibodies. J Clin Endocrinol Metab 56:251–254PubMedGoogle Scholar
  103. 103.
    Iwatani Y, Hidaka Y, Matsuzuka F, Kuma K, Amino N (1993) Intrathyroidal lymphocyte subsets, including unusual CD4+ CD8+ cells and CD3loTCR alpha beta lo/-CD4-CD8 cells, in autoimmune thyroid disease. Clin Exp Immunol 93:430–436PubMedGoogle Scholar
  104. 104.
    Weetman AP, Volkman DJ, Burman KD, et al (1986) The production and characterization of thyroid-derived T-cell lines in Graves’ disease and Hashimoto’s thyroiditis. Clin Immunol Immunopathol 39:139–150PubMedCrossRefGoogle Scholar
  105. 105.
    McIntosh RS, Watson PF, Weetman AP (1997) Analysis of the T cell receptor V alpha repertoire in Hashimoto’s thyroiditis: evidence for the restricted accumulation of CD8+ T cells in the absence of CD4+ T cell restriction. J Clin Endocrinol Metab 82:1140–1146PubMedCrossRefGoogle Scholar
  106. 106.
    Kossev P, Livolsi V (1999) Lymphoid lesions of the thyroid: review in light of the revised European-American lymphoma classification and upcoming World Health Organization classification. Thyroid 9:1273–1280PubMedGoogle Scholar
  107. 107.
    Lam KY, Lo CY, Kwong DL, Lee J, Srivastava G (1999) Malignant lymphoma of the thyroid. A 30-year clinicopathologic experience and an evaluation of the presence of Epstein-Barr virus. Am J Clin Pathol 112:263–270PubMedGoogle Scholar
  108. 108.
    Baloch ZW, Solomon AC, LiVolsi VA (2000) Primary mucoepidermoid carcinoma and sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid gland: a report of nine cases. Mod Pathol 13:802–807PubMedCrossRefGoogle Scholar
  109. 109.
    Katz SM, Vickery AL Jr (1974) The fibrous variant of Hashimoto’s thyroiditis. Hum Pathol 5:161–170PubMedCrossRefGoogle Scholar
  110. 110.
    Papi G, Corrado S, Carapezzi C, De Gaetani C, Carani C (2003) Riedel’s thyroiditis and fibrous variant of Hashimoto’s thyroiditis: a clinicopathological and immunohistochemical study. J Endocrinol Invest 26:444–449PubMedGoogle Scholar
  111. 111.
    LiVolsi VA (1993) Postpartum thyroiditis. The pathology slowly unravels. Am J Clin Pathol 100:193–195PubMedGoogle Scholar
  112. 112.
    Weetman AP, Fung HY, Richards CJ, McGregor AM (1990) IgG subclass distribution and relative functional affinity of thyroid microsomal antibodies in postpartum thyroiditis. Eur J Clin Invest 20:133–136PubMedGoogle Scholar
  113. 113.
    Papi G, Corrado S, Carapezzi C, Corsello SM (2003) Postpartum thyroiditis presenting as a cold nodule and evolving to Graves’ disease. Int J Clin Pract 57:556–558PubMedGoogle Scholar
  114. 114.
    Williams ED, Doniach I (1962) The post-mortem incidence of focal thyroiditis. J Pathol Bacteriol 83:255–264PubMedCrossRefGoogle Scholar
  115. 115.
    Weaver DR, Deodhar SD, Hazard JB (1966) A characterization of focal lymphocytic thyroiditis. Cleve Clin Q 33:59–72PubMedGoogle Scholar
  116. 116.
    Vollenweider R, Stolkin I, Hedinger C (1982) [Focal lymphocytic thyroiditis and iodized salt prophylaxis. Comparative studies on goiter specimens at the Institute of Pathology of Zurich University]. Schweiz Med Wochenschr 112:482–488PubMedGoogle Scholar
  117. 117.
    Katsikas D, Shorthouse A, Taylor S (1976) Riedel’s thyroiditis. Br J Surg 63:929–931PubMedGoogle Scholar
  118. 118.
    Arnott E, Greaves D (1965) Orbital involvement in Riedel’s thyroiditis. Br J Ophthalmol 491:1–5Google Scholar
  119. 119.
    Bartholomew L, Cain J, Woolner L, Utz D, Ferris D (1963) Sclerosing cholangitis. Its possible association with Riedel’s struma and fibrous retroperitonitis. N Engl J Med 269:8–12PubMedCrossRefGoogle Scholar
  120. 120.
    Davies D, Furness P (1984) Riedel’s thyroiditis with multiple organ fibrosis. Thorax 39:959–960PubMedGoogle Scholar
  121. 121.
    Rao C, Ferguson G, Kyle V (1973) Retroperitoneal fibrosis associated with Riedel’s struma. Can Med Assoc J 108:1019–1021PubMedGoogle Scholar
  122. 122.
    Schwaegerle S, Bauer T, Esselstyn C (1988) Riedel’s thyroiditis. Am J Clin Pathol 90:715–722PubMedGoogle Scholar
  123. 123.
    Papi G, Corrado S, Cesinaro AM, Novelli L, Smerieri A, Carapezzi C (2002) Riedel’s thyroiditis: clinical, pathological and imaging features. Int J Clin Pract 56:65–67PubMedGoogle Scholar
  124. 124.
    Casoli P, Tumiati B (1999) Hypoparathyroidism secondary to Riedel’s thyroiditis. A case report and a review of the literature. Ann Ital Med Int 14:54–57PubMedGoogle Scholar
  125. 125.
    Meij S, Hausman R (1978) Occlusive phlebitis, a diagnostic feature in Riedel’s thyroiditis. Virchows Arch [A]. 377:339–349CrossRefGoogle Scholar
  126. 126.
    Harach HR, Williams ED (1983) Fibrous thyroiditis: an immunopathological study. Histopathology 7:739–751PubMedGoogle Scholar
  127. 127.
    Baloch ZW, Feldman MD, LiVolsi VA (2000) Combined Riedel’s disease and fibrosing Hashimoto’s thyroiditis: a report of three cases with two showing coexisting papillary carcinoma. Endocr Pathol 11:157–163PubMedCrossRefGoogle Scholar
  128. 128.
    Bogazzi F, Bartalena L, Gasperi M, Braverman LE, Martino E (2001) The various effects of amiodarone on thyroid function. Thyroid 11:511–519PubMedCrossRefGoogle Scholar
  129. 129.
    Smyrk T, Goellner J, Brennan M, Carney J (1987) Pathology of the thyroid in amiodarone associated thyrotoxicosis. Am J Surg Pathol 11:197–204PubMedCrossRefGoogle Scholar
  130. 130.
    Cetta F, Montalto G, Petracci M, Fusco A (1997) Thyroid cancer and the Chernobyl accident. Are long-term and long-distance side effects of fall-out radiation greater than estimated? J Clin Endocrinol Metab 82:2015–2017PubMedCrossRefGoogle Scholar
  131. 131.
    Carr RF, LiVolsi VA (1989) Morphologic changes in the thyroid after irradiation for Hodgkin’s and non-Hodgkin’s lymphoma. Cancer 64:825–829PubMedCrossRefGoogle Scholar
  132. 132.
    Aizawa T, Watanabe T, Suzuki N, et al (1998) Radiation-induced painless thyrotoxic thyroiditis followed by hypothyroidism: a case report and literature review. Thyroid 8:273–275PubMedGoogle Scholar
  133. 133.
    Avetisian IL, Gulchiy NV, Demidiuk AP, Stashuk AV (1996) Thyroid pathology in residents of the Kiev region, Ukraine, during pre-and post-Chernobyl periods. J Environ Pathol Toxicol Oncol 15:233–237PubMedGoogle Scholar
  134. 134.
    Nishiyama K, Kozuka T, Higashihara T, Miyauchi K, Okagawa K (1996) Acute radiation thyroiditis. Int J Radiat Oncol Biol Phys 36:1221–1224PubMedCrossRefGoogle Scholar
  135. 135.
    Lindsay S, Dailey M, Jones M (1954) Histologic effects of various types of ionizing radiation on normal and hyperplastic human thyroid glands. J Clin Endocrinol Metab 14:1179–1219PubMedGoogle Scholar
  136. 136.
    Goldsmith JD, Lai ML, Daniele GM, Tomaszewski JE, LiVolsi VA (2000) Amyloid goiter: report of two cases and review of the literature. Endocr Pract 6:318–323PubMedGoogle Scholar
  137. 137.
    Hamed G, Heffess CS, Shmookler BM, Wenig BM (1995) Amyloid goiter. A clinicopathologic study of 14 cases and review of the literature. Am J Clin Pathol 104:306–312PubMedGoogle Scholar
  138. 138.
    Pastolero GC, Asa SL (1994) Drug-related pigmentation of the thyroid associated with papillary carcinoma. Arch Pathol Lab Med 118:79–83PubMedGoogle Scholar
  139. 139.
    Gordon G, Sparano B, Kramer A, Kelly R, Latropoulos M (1984) Thyroid gland pigmentation and minocycline therapy. Am J Pathol 117:98–109PubMedGoogle Scholar
  140. 140.
    LiVolsi VA, Feind CR (1976) Parathyroid adenoma and nonmedullary thyroid carcinoma. Cancer 38:1391–1393PubMedCrossRefGoogle Scholar
  141. 141.
    Mai KT, Landry DC, Thomas J, et al (2001) Follicular adenoma with papillary architecture: a lesion mimicking papillary thyroid carcinoma. Histopathology 39:25–32PubMedCrossRefGoogle Scholar
  142. 142.
    LiVolsi VA (1996) Well differentiated thyroid carcinoma. Clin Oncol (R Coll Radiol) 8:281–288Google Scholar
  143. 143.
    LiVolsi VA, Baloch ZW (2004) Follicular neoplasms of the thyroid: view, biases, and experiences. Adv Anat Pathol 11:279–287PubMedCrossRefGoogle Scholar
  144. 144.
    LiVolsi VA, Merino MJ (1994) Worrisome histologic alterations following fine-needle aspiration of the thyroid (WHAFFT). Pathol Annu 29:99–120PubMedGoogle Scholar
  145. 145.
    Oyama T, Vickery AL Jr, Preffer FI, Colvin RB (1994) A comparative study of flow cytometry and histopathologic findings in thyroid follicular carcinomas and adenomas. Hum Pathol 25:271–275PubMedCrossRefGoogle Scholar
  146. 146.
    Harlow SP, Duda RB, Bauer KD (1992) Diagnostic utility of DNA content flow cytometry in follicular neoplasms of the thyroid. J Surg Oncol 50:1–6PubMedGoogle Scholar
  147. 147.
    Carney JA, Ryan J, Goellner JR (1987) Hyalinizing trabecular adenoma of the thyroid gland. Am J Surg Pathol 11:583–591PubMedCrossRefGoogle Scholar
  148. 148.
    Chetty R, Beydoun R, LiVolsi VA (1994) Paragangliomalike (hyalinizing trabecular) adenoma of the thyroid revisited. Pathology 26:429–431PubMedCrossRefGoogle Scholar
  149. 149.
    LiVolsi VA (2000) Hyalinizing trabecular tumor of the thyroid: adenoma, carcinoma, or neoplasm of uncertain malignant potential? Am J Surg Pathol 24:1683–1684PubMedCrossRefGoogle Scholar
  150. 150.
    Fonseca E, Nesland J, Sobrinho-Simoes M (1997) Expression of stratified epithelial type cytokeratins in hyalinizing trabecular adenoma supports their relationship with papillary carcinoma of the thyroid. Histopathology 31:330–335PubMedCrossRefGoogle Scholar
  151. 151.
    Papotti M, Volante M, Giuliano A, et al (2000) RET/PTC activation in hyalinizing trabecular tumors of the thyroid. Am J Surg Pathol 24:1615–1621PubMedCrossRefGoogle Scholar
  152. 152.
    Hazard JB, Kenyon R (1954) Atypical adenoma of the thyroid. Arch Pathol 58:554–563Google Scholar
  153. 153.
    Fukunaga M, Shinozaki N, Endo Y, Ushigome S (1992) Atypical adenoma of the thyroid. A clinicopathologic and flow cytometric DNA study in comparison with other follicular neoplasms. Acta Pathol Jpn 42:632–638PubMedGoogle Scholar
  154. 154.
    Lang W, Georgii A, Atay Z (1977) [Differential diagnosis between atypical adenoma and follicular carcinoma of the thyroid gland (author’s translation)]. Verh Dtsch Ges Pathol 61:275–279PubMedGoogle Scholar
  155. 155.
    Carcangiu ML, Steeper T, Zampi G, Rosai J (1985) Anaplastic thyroid carcinoma. A study of 70 cases. Am J Clin Pathol 83:135–158PubMedGoogle Scholar
  156. 156.
    Carcangui ML ZG, Pupi A, Castagnoli A, Rosai J (1985) Papillary carcinoma of the thyroid: a clinico-pathologic study of 241 cases treated at the University of Florence, Italy. Cancer 55:805–828CrossRefGoogle Scholar
  157. 157.
    LiVolsi VA (1992) Papillary neoplasms of the thyroid. Pathologic and prognostic features. Am J Clin Pathol 97:426–434PubMedGoogle Scholar
  158. 158.
    Mazzaferi EYR (1981) Papillary thyroid carcinoma: a 10-year follow-up report of the impact of therapy in 576 patients. Am J Med 70:511–518CrossRefGoogle Scholar
  159. 159.
    Furlan JC, Bedard YC, Rosen IB (2004) Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas. J Am Coll Surg 198:341–348PubMedCrossRefGoogle Scholar
  160. 160.
    Mills SE, Allen MS Jr (1986) Congenital occult papillary carcinoma of the thyroid gland. Hum Pathol 17:1179–1181PubMedGoogle Scholar
  161. 161.
    Schottenfeld D, Gershman ST (1977) Epidemiology of thyroid cancer, part II. Clin Bull 7:98–104PubMedGoogle Scholar
  162. 162.
    Williams ED, Doniach I, Bjarnason O, Michie W (1977) Thyroid cancer in an iodide rich area: a histopathological study. Cancer 39:215–222PubMedCrossRefGoogle Scholar
  163. 163.
    Harach HR, Escalante DA, Day ES (2002) Thyroid cancer and thyroiditis in Salta, Argentina: a 40-yr study in relation to iodine prophylaxis. Endocr Pathol 13:175–181PubMedCrossRefGoogle Scholar
  164. 164.
    Petrova GV, Tereshchenko VP, Avetis’ian IL (1996) [The dynamics of thyroid diseases in the inhabitants of Kiev and Kiev Province after the accident at the Chernobyl Atomic Electric Power Station]. Lik Sprava 1996:67–70Google Scholar
  165. 165.
    Ron E, Kleinerman RA, Boice JD, LiVolsi VA, Flannery JT, Fraumeni JF (1987) A population-based case-control study of thyroid cancer. J Natl Cancer Inst 79:1–12PubMedGoogle Scholar
  166. 166.
    Pacini F, Vorontsova T, Molinaro E, et al (1999) Thyroid consequences of the Chernobyl nuclear accident. Acta Paediatr Suppl 88:23–27PubMedCrossRefGoogle Scholar
  167. 167.
    Tamimi DM (2002) The association between chronic lymphocytic thyroiditis and thyroid tumors. Int J Surg Pathol 10:141–146PubMedGoogle Scholar
  168. 168.
    Nikiforova MN, Caudill CM, Biddinger P, Nikiforov YE (2002) Prevalence of RET/PTC rearrangements in Hashimoto’s thyroiditis and papillary thyroid carcinomas. Int J Surg Pathol 10:15–22PubMedGoogle Scholar
  169. 169.
    Hunt JL, Baloch Z, Barnes EL, et al (2002) Loss of heterozygosity mutations of tumor suppressor genes in cytologically atypical areas of chronic lymphocytic thyroiditis. Endocr Pathol 13:23–30CrossRefGoogle Scholar
  170. 170.
    La Vecchia C, Ron E, Franceschi S, et al (1999) A pooled analysis of case-control studies of thyroid cancer. III. Oral contraceptives, menopausal replacement therapy and other female hormones. Cancer Causes Control 10:157–166PubMedCrossRefGoogle Scholar
  171. 171.
    Diaz NM, Mazoujian G, Wick MR (1991) Estrogen-receptor protein in thyroid neoplasms. An immunohistochemical analysis of papillary carcinoma, follicular carcinoma, and follicular adenoma. Arch Pathol Lab Med 115:1203–1207PubMedGoogle Scholar
  172. 172.
    Cetta F, Montalto G, Gori M, Curia MC, Cama A, Olschwang S (2000) Germline mutations of the APC gene in patients with familial adenomatous polyposis-associated thyroid carcinoma: results from a European cooperative study. J Clin Endocrinol Metab 85:286–292PubMedCrossRefGoogle Scholar
  173. 173.
    Harach HR, Soubeyran I, Brown A, Bonneau D, Longy M (1999) Thyroid pathologic findings in patients with Cowden disease. Ann Diagn Pathol 3:331–340PubMedCrossRefGoogle Scholar
  174. 174.
    Haggitt RC, Reid BJ (1986) Hereditary gastrointestinal polyposis syndromes. Am J Surg Pathol 10:871–887PubMedCrossRefGoogle Scholar
  175. 175.
    Cetta F, Toti P, Petracci M, et al (1997) Thyroid carcinoma associated with familial adenomatous polyposis. Histopathology 31:231–236PubMedCrossRefGoogle Scholar
  176. 176.
    Cetta F, Olschwang S, Petracci M, et al (1998) Genetic alterations in thyroid carcinoma associated with familial adenomatous polyposis: clinical implications and suggestions for early detection. World J Surg 22:1231–1236PubMedCrossRefGoogle Scholar
  177. 177.
    Cetta F, Chiappetta G, Melillo RM, et al (1998) The ret/ptc1 oncogene is activated in familial adenomatous polyposis-associated thyroid papillary carcinomas. J Clin Endocrinol Metab 83:1003–1006PubMedCrossRefGoogle Scholar
  178. 178.
    Dahia PL, Marsh DJ, Zheng Z, et al (1997) Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors. Cancer Res 57:4710–4713PubMedGoogle Scholar
  179. 179.
    Wirtzfeld DA, Petrelli NJ, Rodriguez-Bigas MA (2001) Hamartomatous polyposis syndromes: molecular genetics, neoplastic risk, and surveillance recommendations. Ann Surg Oncol 8:319–327PubMedCrossRefGoogle Scholar
  180. 180.
    Meshikhes AW, Butt MS, Al-Saihati BA (2004) Combined parathyroid adenoma and an occult papillary carcinoma. Saudi Med J 25:1707–1710PubMedGoogle Scholar
  181. 181.
    Dralle H, Altenahr E (1979) Pituitary adenoma, primary parathyroid hyperplasia and papillary (non-medullary) thyroid carcinoma. A case of multiple endocrine neoplasia (MEN). Virchows Arch A Pathol Anat Histol 381:179–187PubMedCrossRefGoogle Scholar
  182. 182.
    Francis IM, Das DK, Sheikh ZA, Sharma PN, Gupta SK (1995) Role of nuclear grooves in the diagnosis of papillary thyroid carcinoma. A quantitative assessment on fine needle aspiration smears. Acta Cytol 39:409–415PubMedGoogle Scholar
  183. 183.
    Riazmontazer N, Bedayat G (1991) Psammoma bodies in fine needle aspirates from thyroids containing nontoxic hyperplastic nodular goiters. Acta Cytol 35:563–566PubMedGoogle Scholar
  184. 184.
    Hunt JL, Barnes EL (2003) Non-tumor-associated psammoma bodies in the thyroid. Am J Clin Pathol 119:90–94PubMedCrossRefGoogle Scholar
  185. 185.
    Hosoya T, Sakamoto A, Kasai N, Sakurai K (1983) [Nodal psammoma body in thyroid cancer as an indicator of cancer metastasis to the lymph node]. Gan No Rinsho 29:1336–1339PubMedGoogle Scholar
  186. 186.
    Mancini A, Rabitti C, Conte G, Gullotta G, De Marinis L (1993) [Lymphocytic infiltration in thyroid neoplasms. Preliminary prognostic assessments]. Minerva Chir 48:1283–1288PubMedGoogle Scholar
  187. 187.
    Gomez Saez JM, Gomez Arnaiz N, Sahun de la Vega M, Soler Ramon J (1997) [Prevalence and significance of lymphocyte infiltration in papillary carcinoma of the thyroid gland]. Ann Med Interna 14:403–405Google Scholar
  188. 188.
    Ruiz-Velasco R, Waisman J, Van Herle AJ (1978) Cystic papillary carcinoma of the thyroid gland. Diagnosis by needle aspiration with transmission electron microscopy. Acta Cytol 22:38–42PubMedGoogle Scholar
  189. 189.
    de los Santos ET, Keyhani-Rofagha S, Cunningham JJ, Mazzaferri EL (1990) Cystic thyroid nodules. The dilemma of malignant lesions. Arch Intern Med 150:1422–1427PubMedCrossRefGoogle Scholar
  190. 190.
    Namba H, Matsuo K, Fagin JA (1990) Clonal composition of benign and malignant human thyroid tumors. J Clin Invest 86:120–125PubMedGoogle Scholar
  191. 191.
    Fusco A, Chiappetta G, Hui P, et al (2002) Assessment of RET/PTC oncogene activation and clonality in thyroid nodules with incomplete morphological evidence of papillary carcinoma: a search for the early precursors of papillary cancer. Am J Pathol 160:2157–2167PubMedGoogle Scholar
  192. 192.
    Hunt JL, LiVolsi VA, Baloch ZW, et al (2003) Microscopic papillary thyroid carcinoma compared with clinical carcinomas by loss of heterozygosity mutational profile. Am J Surg Pathol 27:159–166PubMedCrossRefGoogle Scholar
  193. 193.
    Petkov R, Gavrailov M, Mikhailov I, Todorov G, Kutev N (1995) [Differentiated thyroid cancer: a study of the pathomorphological variants in 216 patients]. Khirurgiia 48:11–12Google Scholar
  194. 194.
    Akslen LA, LiVolsi VA (2000) Prognostic significance of histologic grading compared with subclassification of papillary thyroid carcinoma [see comments]. Cancer 88:1902–1908PubMedCrossRefGoogle Scholar
  195. 195.
    Paessler M, Kreisel FH, LiVolsi VA, Akslen LA, Baloch ZW (2002) Can we rely on pathologic parameters to define conservative treatment of papillary thyroid carcinoma? Int J Surg Pathol 10:267–272PubMedGoogle Scholar
  196. 196.
    Santini L, Pezzullo L, D’Arco E, De Rosa N, Guerriero O, Salza C (1989) Lymph node metastases from an occult sclerosing carcinoma of the thyroid. A case report. Ital J Surg Sci 19:277–279PubMedGoogle Scholar
  197. 197.
    Akslen LA, LiVolsi VA (2000) Poorly differentiated thyroid carcinoma: it is important. Am J Surg Pathol 24:310–313PubMedCrossRefGoogle Scholar
  198. 198.
    Tachikawa T, Kumazawa H, Kyomoto R, Yukawa H, Yamashita T, Nishikawa M (2001) [Clinical study on prognostic factors in thyroid carcinoma]. Nippon Jibiinkoka Gakkai Kaiho 104:157–164PubMedGoogle Scholar
  199. 199.
    Mazzaferri EL (1987) Papillary thyroid carcinoma: factors influencing prognosis and current therapy. Semin Oncol 14:315–332PubMedGoogle Scholar
  200. 200.
    Prasad ML, Pellegata NS, Huang Y, Nagaraja HN, Chapelle Ade L, Kloos RT (2005) Galectin-3, fibronectin-1, CITED-1, HBME1 and cytokeratin-19 immunohisto-chemistry is useful for the differential diagnosis of thyroid tumors. Mod Pathol 18:48–57PubMedCrossRefGoogle Scholar
  201. 201.
    Casey MB, Lohse CM, Lloyd RV (2003) Distinction between papillary thyroid hyperplasia and papillary thyroid carcinoma by immunohistochemical staining for cytokeratin 19, galectin-3, and HBME-1. Endocr Pathol 14:55–60PubMedCrossRefGoogle Scholar
  202. 202.
    Cheung CC, Ezzat S, Freeman JL, Rosen IB, Asa SL (2001) Immunohistochemical diagnosis of papillary thyroid carcinoma. Mod Pathol 14:338–342PubMedCrossRefGoogle Scholar
  203. 203.
    Eimoto T, Naito H, Hamada S, Masuda M, Harada T, Kikuchi M (1987) Papillary carcinoma of the thyroid. A histochemical, immunohistochemical and ultrastructural study with special reference to the follicular variant. Acta Pathol Jpn 37:1563–1579PubMedGoogle Scholar
  204. 204.
    van Hoeven KH, Kovatich AJ, Miettinen M (1998) Immunocytochemical evaluation of HBME-1, CA 19-9, and CD-15 (Leu-M1) in fine-needle aspirates of thyroid nodules. Diagn Cytopathol 18:93–97PubMedCrossRefGoogle Scholar
  205. 205.
    Baloch ZW, Abraham S, Roberts S, LiVolsi VA (1999) Differential expression of cytokeratins in follicular variant of papillary carcinoma: an immunohistochemical study and its diagnostic utility. Hum Pathol 30:1166–1171PubMedCrossRefGoogle Scholar
  206. 206.
    Baloch ZW, LiVolsi VA (2002) The quest for a magic tumor marker: continuing saga in the diagnosis of the follicular lesions of thyroid. Am J Clin Pathol 118:165–166PubMedCrossRefGoogle Scholar
  207. 207.
    Batistatou A, Zolota V, Scopa CD (2002) S-100 protein+ dendritiC-cells and CD34+ dendritic interstitial cells in thyroid lesions. Endocr Pathol 13:111–115PubMedCrossRefGoogle Scholar
  208. 208.
    Hiasa Y, Nishioka H, Kitahori Y, et al (1991) Immunohistochemical detection of estrogen receptors in paraffin sections of human thyroid tissues. Oncology 48:421–424PubMedCrossRefGoogle Scholar
  209. 209.
    Khan A, Baker SP, Patwardhan NA, Pullman JM (1998) CD57 (Leu-7) expression is helpful in diagnosis of the follicular variant of papillary thyroid carcinoma. Virchows Arch 432:427–432PubMedCrossRefGoogle Scholar
  210. 210.
    Miettinen M, Karkkainen P (1996) Differential reactivity of HBME-1 and CD15 antibodies in benign and malignant thyroid tumours. Preferential reactivity with malignant tumours. Virchows Arch 429:213–219PubMedCrossRefGoogle Scholar
  211. 211.
    Zedenius J, Auer G, Backdahl M, et al (1992) Follicular tumors of the thyroid gland: diagnosis, clinical aspects and nuclear DNA analysis. World J Surg 16:589–594PubMedCrossRefGoogle Scholar
  212. 212.
    Grieco M, Santoro M, Berlingieri MT, et al (1990) PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell 60:557–563PubMedCrossRefGoogle Scholar
  213. 213.
    Santoro M, Rosati R, Grieco M, et al (1990) The ret protooncogene is consistently expressed in human pheochromocytomas and thyroid medullary carcinomas. Oncogene 5:1595–1598PubMedGoogle Scholar
  214. 214.
    Santoro M, Dathan NA, Berlingieri MT, et al (1994) Molecular characterization of RET/PTC3: a novel rearranged version of the RET proto-oncogene in a human thyroid papillary carcinoma. Oncogene 9:509–516PubMedGoogle Scholar
  215. 215.
    Inaba M, Umemura S, Satoh H, et al (2003) Expression of RET in follicular cell-derived tumors of the thyroid gland: prevalence and implication of morphological type. Pathol Int 53:146–153PubMedCrossRefGoogle Scholar
  216. 216.
    Nikiforov YE (2002) RET/PTC rearrangement in thyroid tumors. Endocr Pathol 13:3–16PubMedCrossRefGoogle Scholar
  217. 217.
    Jhiang SM, Cho JY, Furminger TL, et al (1998) Thyroid carcinomas in RET/PTC transgenic mice. Recent Results Cancer Res 154:265–270PubMedGoogle Scholar
  218. 218.
    Fischer AH, Bond JA, Taysavang P, Eugene B, Wynford-Thomas D (1998) Papillary thyroid carcinoma oncogene (RET/PTC) alters the nuclear envelope and chromatin structure. Am J Pathol 153:1443–1450PubMedGoogle Scholar
  219. 219.
    Fusco A, Santoro M, Grieco M, et al (1995) RET/PTC activation in human thyroid carcinomas. J Endocrinol Invest 18:127–129PubMedGoogle Scholar
  220. 220.
    Nikiforov YE, Rowland JM, Bove KE, Monforte-Munoz H, Fagin JA (1997) Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children. Cancer Res 57:1690–1694PubMedGoogle Scholar
  221. 221.
    Bounacer A, Wicker R, Schlumberger M, Sarasin A, Suarez HG (1997) Oncogenic rearrangements of the ret proto-oncogene in thyroid tumors induced after exposure to ionizing radiation. Biochimie 79:619–623PubMedCrossRefGoogle Scholar
  222. 222.
    Wirtschafter A, Schmidt R, Rosen D, et al (1997) Expression of the RET/PTC fusion gene as a marker for papillary carcinoma in Hashimoto’s thyroiditis [see comments]. Laryngoscope 107:95–100PubMedCrossRefGoogle Scholar
  223. 223.
    Sheils O, Smyth P, Finn S, Sweeney EC, O’Leary JJ (2002) RET/PTC rearrangements in Hashimoto’s thyroiditis. Int J Surg Pathol 10:167–168; discussion 168–169PubMedGoogle Scholar
  224. 224.
    Elisei R, Romei C, Vorontsova T, et al (2001) RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults. J Clin Endocrinol Metab 86:3211–3216PubMedCrossRefGoogle Scholar
  225. 225.
    Cohen Y, Xing M, Mambo E, et al (2003) BRAF mutation in papillary thyroid carcinoma. J Natl Cancer Inst 95:625–627PubMedGoogle Scholar
  226. 226.
    Nikiforova MN, Kimura ET, Gandhi M, et al (2003) BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. J Clin Endocrinol Metab 88:5399–5404PubMedCrossRefGoogle Scholar
  227. 227.
    Soares P, Trovisco V, Rocha AS, et al (2004) BRAF mutations typical of papillary thyroid carcinoma are more frequently detected in undifferentiated than in insular and insular-like poorly differentiated carcinomas. Virchows Arch 444:572–576PubMedCrossRefGoogle Scholar
  228. 228.
    Puxeddu E, Moretti S, Elisei R, et al (2004) BRAF(V599E) mutation is the leading genetic event in adult sporadic papillary thyroid carcinomas. J Clin Endocrinol Metab 89:2414–2420PubMedCrossRefGoogle Scholar
  229. 229.
    Begum S, Rosenbaum E, Henrique R, Cohen Y, Sidransky D, Westra WH (2004) BRAF mutations in anaplastic thyroid carcinoma: implications for tumor origin, diagnosis and treatment. Mod Pathol 17:1359–1363PubMedCrossRefGoogle Scholar
  230. 230.
    Mazzaferri EL (1999) An overview of the management of papillary and follicular thyroid carcinoma. Thyroid 9:421–427PubMedGoogle Scholar
  231. 231.
    Kjellman P, Learoyd DL, Messina M, et al (2001) Expression of the RET proto-oncogene in papillary thyroid carcinoma and its correlation with clinical outcome. Br J Surg 88:557–563PubMedCrossRefGoogle Scholar
  232. 232.
    Basolo F, Molinaro E, Agate L, et al (2001) RET protein expression has no prognostic impact on the long-term outcome of papillary thyroid carcinoma. Eur J Endocrinol 145:599–604PubMedCrossRefGoogle Scholar
  233. 233.
    Cetta F, Gori M, Raffaelli N, Baldi C, Montalto G (1999) Comment on clinical and prognostic relevance of Ret-PTC activation in patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 84:2257–2258PubMedCrossRefGoogle Scholar
  234. 234.
    Kim JY, Cho H, Rhee BD, Kim HY (2002) Expression of CD44 and cyclin D1 in fine needle aspiration cytology of papillary thyroid carcinoma. Acta Cytol 46:679–683PubMedGoogle Scholar
  235. 235.
    Takeuchi Y, Daa T, Kashima K, Yokoyama S, Nakayama I, Noguchi S (1999) Mutations of p53 in thyroid carcinoma with an insular component. Thyroid 9:377–381PubMedGoogle Scholar
  236. 236.
    Basolo F, Caligo MA, Pinchera A, et al (2000) Cyclin D1 overexpression in thyroid carcinomas: relation with clinico-pathological parameters, retinoblastoma gene product, and Ki67 labeling index. Thyroid 10:741–746PubMedGoogle Scholar
  237. 237.
    Lee A, LiVolsi VA, Baloch ZW (2000) Expression of DNA topoisomerase IIalpha in thyroid neoplasia. Mod Pathol 13:396–400PubMedCrossRefGoogle Scholar
  238. 238.
    Tallini G, Garcia-Rostan G, Herrero A, et al (1999) Downregulation of p27KIP1 and Ki67/Mib1 labeling index support the classification of thyroid carcinoma into prognostically relevant categories. Am J Surg Pathol 23:678–685PubMedCrossRefGoogle Scholar
  239. 239.
    DeLellis RA, Lloyd RD, Heitz PU, Eng C (eds) (2004) WHO: pathology and genetics. Tumours of endocrine organs. In: Kleihues P, Sobin LE (eds) WHO classification of tumours. IARC Press, Lyon, FranceGoogle Scholar
  240. 240.
    Rodriguez JM, Moreno A, Parrilla P, et al (1997) Papillary thyroid microcarcinoma: clinical study and prognosis. Eur J Surg 163:255–259PubMedGoogle Scholar
  241. 241.
    Hay ID, Grant CS, van Heerden JA, Goellner JR, Ebersold JR, Bergstralh EJ (1992) Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery 112:1139–1146; discussion 1146–1147PubMedGoogle Scholar
  242. 242.
    Braga M, Graf H, Ogata A, Batista J, Hakim NC (2002) Aggressive behavior of papillary microcarcinoma in a patient with Graves’ disease initially presenting as cystic neck mass. J Endocrinol Invest 25:250–253PubMedGoogle Scholar
  243. 243.
    Fernandez-Real JM, Ricart W (1999) Familial papillary thyroid microcarcinoma. Lancet 353:1973–1974PubMedCrossRefGoogle Scholar
  244. 244.
    Lupoli G, Vitale G, Caraglia M, et al (1999) Familial papillary thyroid microcarcinoma: a new clinical entity. Lancet 353:637–639PubMedCrossRefGoogle Scholar
  245. 245.
    Lindsay S (1960) Carcinoma of the thyroid gland: a clinical and pathologic study of 239 patients at the University of California Hospital. Springfield, ILGoogle Scholar
  246. 246.
    Chen KTC, Rosai J (1977) Follicular variant of thyroid papillary carcinoma: a clinicopathologic study of six cases. Am J Surg Pathol 1:123–130Google Scholar
  247. 247.
    LiVolsi VA, Asa SL (1994) The demise of follicular carcinoma of the thyroid gland. Thyroid 4:233–236PubMedGoogle Scholar
  248. 248.
    Baloch ZW, Gupta PK, Yu GH, Sack MJ, LiVolsi VA (1999) Follicular variant of papillary carcinoma. Cytologic and histologic correlation. Am J Clin Pathol 111:216–222PubMedGoogle Scholar
  249. 249.
    Baloch Z, LiVolsi VA, Henricks WH, Sebak BA (2002) Encapsulated follicular variant of papillary thyroid carcinoma. Am J Clin Pathol 118:603–605; discussion 605–606PubMedCrossRefGoogle Scholar
  250. 250.
    Tielens ET, Sherman SI, Hruban RH, Ladenson PW (1994) Follicular variant of papillary thyroid carcinoma. A clinicopathologic study. Cancer 73:424–431PubMedCrossRefGoogle Scholar
  251. 251.
    Baloch ZW, Livolsi VA (2002) Follicular-patterned lesions of the thyroid: the bane of the pathologist. Am J Clin Pathol 117:143–150PubMedCrossRefGoogle Scholar
  252. 252.
    Mizukami Y, Nonomura A, Michigishi T, Ohmura K, Noguchi M, Ishizaki T (1995) Diffuse follicular variant of papillary carcinoma of the thyroid. Histopathology 27:575–577PubMedGoogle Scholar
  253. 253.
    Ivanova R, Soares P, Castro P, Sobrinho-Simoes M (2002) Diffuse (or multinodular) follicular variant of papillary thyroid carcinoma: a clinicopathologic and immunohistochemical analysis of ten cases of an aggressive form of differentiated thyroid carcinoma. Virchows Arch 440:418–424PubMedCrossRefGoogle Scholar
  254. 254.
    Williams ED, Abrosimov A, Bogdanova TI, Roasi J, Sidorov Y, Thomas GA (2000) Two proposals regarding the terminology of thyroid tumors. Guest Editorial. Int J Surg Pathol 8:181–183PubMedGoogle Scholar
  255. 255.
    Johnson THLR, Thompson NW, Beierwalters WH, Sisson JC (1988) Prognostic implications of the tall cell variant of papillary carcinoma. Am J Surg Pathol 12:22–27PubMedGoogle Scholar
  256. 256.
    Sobrinho-Simoes M, Sambade C, Nesland JM, Johannessen JV (1989) Tall cell papillary carcinoma. Am J Surg Pathol 13:79–80PubMedGoogle Scholar
  257. 257.
    Bronner MP, LiVolsi VA (1991) Spindle cell squamous carcinoma of the thyroid: an unusual anaplastic tumor associated with tall cell papillary cancer. Mod Pathol 4:637–643PubMedGoogle Scholar
  258. 258.
    Prendiville S, Burman KD, Ringel MD, et al (2000) Tall cell variant: an aggressive form of papillary thyroid carcinoma. Otolaryngol Head Neck Surg 122:352–357PubMedCrossRefGoogle Scholar
  259. 259.
    Jobran R, Baloch ZW, Aviles V, Rosato EF, Schwartz S, LiVolsi VA (2000) Tall cell papillary carcinoma of the thyroid: metastatic to the pancreas [In Process Citation]. Thyroid 10:185–187PubMedGoogle Scholar
  260. 260.
    Terry J, St John S, Karkowski F, et al (1994) Tall cell papillary thyroid cancer: incidence and prognosis. Am J Surg 168:459–461PubMedCrossRefGoogle Scholar
  261. 261.
    Sobrinho-Simoes M, Nesland JM, Johannessen JV (1988) Columnar-cell carcinoma. Another variant of poorly differentiated carcinoma of the thyroid. Am J Clin Pathol 89:264–267PubMedGoogle Scholar
  262. 262.
    Chan JK (1990) Papillary carcinoma of thyroid: classical and variants. Histol Histopathol 5:241–257PubMedGoogle Scholar
  263. 263.
    Wenig BM, Thompson LDR, Adair CF, Shmookler B, Heffess CF (1998) Thyroid papillary carcinoma of columnar cell type. A clinicopathologic study of 16 cases. Cancer 82:740–753PubMedCrossRefGoogle Scholar
  264. 264.
    Evans HL (1996) Encapsulated columnar-cell carcinoma of the thyroid. A report of four cases suggesting a favorable outcome. Am J Surg Pathol 20:1205–1211PubMedCrossRefGoogle Scholar
  265. 265.
    Apel RL, Asa SL, LiVolsi VA (1995) Papillary Hürthle cell carcinoma with lymphocytic stroma. “Warthin-like tumor” of the thyroid. Am J Surg Pathol 19:810–814PubMedGoogle Scholar
  266. 266.
    Baloch ZW, LiVolsi VA (2000) Warthin-like papillary carcinoma of the thyroid. Arch Pathol Lab Med 124:1192–1195PubMedGoogle Scholar
  267. 267.
    Chan JKC, Tsui MS, Tse CH (1987) Diffuse sclerosing variant of papillary thyroid carcinoma. A histological and immunohistochemical study of three cases. Histopathology 11:191–201PubMedGoogle Scholar
  268. 268.
    Peix JL, Mabrut JY, Van Box Som P, Berger N (1998) [Thyroid cancer in children and adolescents. Clinical aspects, diagnostic problems and special therapeutics]. Ann Endocrinol (Paris) 59:113–120Google Scholar
  269. 269.
    Santoro M, Thomas GA, Vecchio G, et al (2000) Gene rearrangement and Chernobyl related thyroid cancers. Br J Cancer 82:315–322PubMedCrossRefGoogle Scholar
  270. 270.
    Soares J, Limbert E, Sobrinho-Simoes M (1989) Diffuse sclerosing variant of papillary thyroid carcinoma. A clinicopathologic study of 10 cases. Pathol Res Pract 185:200–206PubMedGoogle Scholar
  271. 271.
    Nikiforov YE, Erickson LA, Nikiforova MN, Caudill CM, Lloyd RV (2001) Solid variant of papillary thyroid carcinoma: incidence, clinical-pathologic characteristics, molecular analysis, and biologic behavior. Am J Surg Pathol 25:1478–1484PubMedCrossRefGoogle Scholar
  272. 272.
    Thomas GA, Bunnell H, Cook HA, et al (1999) High prevalence of RET/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET/PTC3 and the solid-follicular variant. J Clin Endocrinol Metab 84:4232–4238PubMedCrossRefGoogle Scholar
  273. 273.
    Sywak M, Pasieka JL, Ogilvie T (2004) A review of thyroid cancer with intermediate differentiation. J Surg Oncol 86:44–54PubMedCrossRefGoogle Scholar
  274. 274.
    Vergilio J, Baloch ZW, LiVolsi VA (2002) Spindle cell metaplasia of the thyroid arising in association with papillary carcinoma and follicular adenoma. Am J Clin Pathol 117:199–204PubMedCrossRefGoogle Scholar
  275. 275.
    Dickersin G, Vickery AL Jr, Smith S (1980) Papillary carcinoma of the thyroid, oxyphil cell type, “clear cell” variant: a light and electron microscopic study. Am J Surg Pathol 4:501–509PubMedGoogle Scholar
  276. 276.
    Berho M, Suster S (1997) The oncocytic variant of papillary carcinoma of the thyroid: a clinicopathologic study of 15 cases. Hum Pathol 28:47–53PubMedCrossRefGoogle Scholar
  277. 277.
    Bisi H, Longatto Filho A, de Camargo RY, Fernandes VS (1993) Thyroid papillary carcinoma lipomatous type: report of two cases. Pathologica 85:761–764PubMedGoogle Scholar
  278. 278.
    Schroder S, Bocker W (1985) Lipomatous lesions of the thyroid gland: a review. Appl Pathol 3:140–149PubMedGoogle Scholar
  279. 279.
    Chan JK, Carcangiu ML, Rosai J (1991) Papillary carcinoma of thyroid with exuberant nodular fasciitislike stroma. Report of three cases. Am J Clin Pathol 95:309–314PubMedGoogle Scholar
  280. 280.
    Cameselle-Teijeiro J, Chan JK (1999) Cribriform-morular variant of papillary carcinoma: a distinctive variant representing the sporadic counterpart of familial adenomatous polyposis-associated thyroid carcinoma? Mod Pathol 12:400–411PubMedGoogle Scholar
  281. 281.
    Hirokawa M, Kuma S, Miyauchi A, et al (2004) Morules in cribriform-morular variant of papillary thyroid carcinoma: immunohistochemical characteristics and distinction from squamous metaplasia. APMIS 112:275–282PubMedCrossRefGoogle Scholar
  282. 282.
    Xu B, Yoshimoto K, Miyauchi A, et al (2003) Cribriform-morular variant of papillary thyroid carcinoma: a pathological and molecular genetic study with evidence of frequent somatic mutations in exon 3 of the beta-catenin gene. J Pathol 199:58–67PubMedCrossRefGoogle Scholar
  283. 283.
    Franssila KO, Ackerman LV, Brown CL, Hedinger CE (1985) Follicular carcinoma. Semin Diagn Pathol 2:101–122PubMedGoogle Scholar
  284. 284.
    Tollefson HR, Shah JP, Huvos AG (1973) Follicular carcinoma of the thyroid. Am J Surg 126:523–528CrossRefGoogle Scholar
  285. 285.
    Wade JS (1975) The aetiology and diagnosis of malignant tumours of the thyroid gland. Br J Surg 62:760–764PubMedGoogle Scholar
  286. 286.
    Jorda M, Gonzalez-Campora R, Mora J, Herrero-Zapatero A, Otal C, Galera H (1993) Prognostic factors in follicular carcinoma of the thyroid. Arch Pathol Lab Med 117:631–635PubMedGoogle Scholar
  287. 287.
    Segal K, Arad A, Lubin E, Shpitzer T, Hadar T, Feinmesser R (1994) Follicular carcinoma of the thyroid. Head Neck 16:533–538PubMedGoogle Scholar
  288. 288.
    Crile G, Pontius K, Hawk W (1985) Factors influencing the survival of patients with follicular carcinoma of the thyroid gland. Surg Gynecol Obstet 160:409–412PubMedGoogle Scholar
  289. 289.
    Schmidt RJ, Wang CA (1986) Encapsulated follicular carcinoma of the thyroid: diagnosis, treatment, and results. Surgery 100:1068–1077PubMedGoogle Scholar
  290. 290.
    Evans HL (1984) Follicular neoplasms of the thyroid. A study of 44 cases followed for a minimum of 10 years with emphasis on differential diagnosis. Cancer 54:535–540PubMedCrossRefGoogle Scholar
  291. 291.
    Thompson LD, Wieneke JA, Paal E, Frommelt RA, Adair CF, Heffess CS (2001) A clinicopathologic study of minimally invasive follicular carcinoma of the thyroid gland with a review of the English literature. Cancer 91:505–524PubMedCrossRefGoogle Scholar
  292. 292.
    Carcangiu ML (1997) Minimally invasive follicular carcinoma. Endocr Pathol 8:231–234PubMedGoogle Scholar
  293. 293.
    Shaha AR, Loree TR, Shah JP (1995) Prognostic factors and risk group analysis in follicular carcinoma of the thyroid. Surgery 118:1131–1136; discussion 1136–1138PubMedCrossRefGoogle Scholar
  294. 294.
    Moore JH Jr, Bacharach B, Choi HY (1985) Anaplastic transformation of metastatic follicular carcinoma of the thyroid. J Surg Oncol 29:216–221PubMedGoogle Scholar
  295. 295.
    D’Avanzo A, Treseler P, Ituarte PH, et al (2004) Follicular thyroid carcinoma: histology and prognosis. Cancer 100:1123–1129PubMedCrossRefGoogle Scholar
  296. 296.
    Jakubiak-Wielganowicz M, Kubiak R, Sygut J, Pomorski L, Kordek R (2003) Usefulness of galectin-3 immunohistochemistry in differential diagnosis between thyroid follicular carcinoma and follicular adenoma. Pol J Pathol 54:111–115PubMedGoogle Scholar
  297. 297.
    Collini P, Sampietro G, Rosai J, Pilotti S (2003) Minimally invasive (encapsulated) follicular carcinoma of the thyroid gland is the low-risk counterpart of widely invasive follicular carcinoma but not of insular carcinoma. Virchows Arch 442:71–76PubMedGoogle Scholar
  298. 298.
    Kahn NF, Perzin KH (1983) Follicular carcinoma of the thyroid: an evaluation of the histologic criteria used for diagnosis. Pathol Ann 18:221–253Google Scholar
  299. 299.
    Udelsman R, Westra WH, Donovan PI, Sohn TA, Cameron JL (2001) Randomized prospective evaluation of frozen-section analysis for follicular neoplasms of the thyroid. Ann Surg 233:716–722PubMedCrossRefGoogle Scholar
  300. 300.
    Leteurtre E, Leroy X, Pattou F, et al (2001) Why do frozen sections have limited value in encapsulated or minimally invasive follicular carcinoma of the thyroid? Am J Clin Pathol 115:370–374PubMedCrossRefGoogle Scholar
  301. 301.
    Paphavasit A, Thompson GB, Hay ID, et al (1997) Follicular and Hürthle cell thyroid neoplasms. Is frozen-section evaluation worthwhile? Arch Surg 132:674–678; discussion 678–680PubMedGoogle Scholar
  302. 302.
    Johannessen JV, Sobrinho-Simoes M (1982) Follicular carcinoma of the human thyroid gland. An ultrastructural study with emphasis on scanning electron microscopy. Diagn Histopathol 5:113–127PubMedGoogle Scholar
  303. 303.
    Backdahl M (1985) Nuclear DNA content and prognosis in papillary, follicular, and medullary carcinomas of the thyroid. Doctoral thesis, Karolinska Medical Institute, Stockholm, SwedenGoogle Scholar
  304. 304.
    Papotti M, Rodriguez J, Pompa RD, Bartolazzi A, Rosai J (2004) Galectin-3 and HBME-1 expression in well-differentiated thyroid tumors with follicular architecture of uncertain malignant potential. Mod Pathol 18:541–546CrossRefGoogle Scholar
  305. 305.
    Rosai J (2003) Immunohistochemical markers of thyroid tumors: significance and diagnostic applications. Tumori 89:517–519PubMedGoogle Scholar
  306. 306.
    Kroll TG, Sarraf P, Pecciarini L, et al (2000) PAX8-PPAR[gamma] 1 fusion in oncogene human thyroid carcinoma. Science 289:1357–1360PubMedCrossRefGoogle Scholar
  307. 307.
    Marques AR, Espadinha C, Catarino AL, et al (2002) Expression of PAX8-PPAR gamma 1 rearrangements in both follicular thyroid carcinomas and adenomas. J Clin Endocrinol Metab 87:3947–3952PubMedCrossRefGoogle Scholar
  308. 308.
    Gustafson KS, LiVolsi VA, Furth EE, Pasha TL, Putt ME, Baloch ZW (2003) Peroxisome proliferator-activated receptor gamma expression in follicular-patterned thyroid lesions. Caveats for the use of immunohistochemical studies. Am J Clin Pathol 120:175–181PubMedCrossRefGoogle Scholar
  309. 309.
    Esapa CT, Johnson SJ, Kendall-Taylor P, Lennard TW, Harris PE (1999) Prevalence of Ras mutations in thyroid neoplasia. Clin Endocrinol 50:529–535CrossRefGoogle Scholar
  310. 310.
    Basolo F, Pisaturo F, Pollina LE, et al (2000) N-ras mutation in poorly differentiated thyroid carcinomas: correlation with bone metastases and inverse correlation to thyroglobulin expression. Thyroid 10:19–23PubMedGoogle Scholar
  311. 311.
    Capella G, Matias-Guiu X, Ampudia X, de Leiva A, Perucho M, Prat J (1996) Ras oncogene mutations in thyroid tumors: polymerase chain reaction-restriction-fragmentlength polymorphism analysis from paraffin-embedded tissues. Diagn Mol Pathol 5:45–52PubMedCrossRefGoogle Scholar
  312. 312.
    Grebe SK, McIver B, Hay ID, et al (1997) Frequent loss of heterozygosity on chromosomes 3p and 17p without VHL or p53 mutations suggests involvement of unidentified tumor suppressor genes in follicular thyroid carcinoma. J Clin Endocrinol Metab 82:3684–3691PubMedCrossRefGoogle Scholar
  313. 313.
    Matsuo K, Tang SH, Fagin JA (1991) Allelotype of human thyroid tumors: loss of chromosome 11q13 sequences in follicular neoplasms. Mol Endocrinol 5:1873–1879PubMedGoogle Scholar
  314. 314.
    Nesland JM, Sobrinho-Simoes MA, Holm R, Sambade MC, Johannessen JV (1985) Hürthle-cell lesions of the thyroid: a combined study using transmission electron microscopy, scanning electron microscopy, and immunocytochemistry. Ultrastruct Pathol 8:269–290PubMedGoogle Scholar
  315. 315.
    Gonzalez-Campora R, Herrero-Zapatero A, Lerma E, Sanchez F, Galera H (1986) Hürthle cell and mitochondrion-rich cell tumors. A clinicopathologic study. Cancer 57:1154–1163PubMedCrossRefGoogle Scholar
  316. 316.
    Thompson N, Dun E, Batsakis J, Nishiyama R (1974) Hürthle cell lesions of the thyroid gland. Surg Gynecol Obstet 139:555–560PubMedGoogle Scholar
  317. 317.
    Gundry S, Burney R, Thompson N, Lloyd R (1983) Total thyroidectomy for Hürthle cell neoplasm of the thyroid gland. Arch Surg 118:529–553PubMedGoogle Scholar
  318. 318.
    Bronner M, LiVolsi V (1988) Oxyphilic (Askanazy/Hürthle cell) tumors of the thyroid: microscopic features predict biologic behavior. Surg Pathol 1:137–150Google Scholar
  319. 319.
    Carcangiu ML, Bianchi S, Savino D, Voynick IM, Rosai J (1991) Follicular Hürthle cell tumors of the thyroid gland. Cancer 68:1944–1953PubMedCrossRefGoogle Scholar
  320. 320.
    Chen H, Nicol TL, Zeiger MA, et al (1998) Hürthle cell neoplasms of the thyroid: are there factors predictive of malignancy? Ann Surg 227:542–546PubMedCrossRefGoogle Scholar
  321. 321.
    Janser JC, Pusel J, Rodier JF, Navarrete E, Rodier D (1989) [Hürthle cell tumor of the thyroid gland. Analysis of a series of 33 cases]. J Chir (Paris) 126:619–624Google Scholar
  322. 322.
    Kanthan R, Radhi JM (1998) Immunohistochemical analysis of thyroid adenomas with Hürthle cells. Pathology 30:4–6PubMedCrossRefGoogle Scholar
  323. 323.
    Bronner MP, Clevenger CV, Edmonds PR, Lowell DM, McFarland MM, LiVolsi VA (1988) Flow cytometric analysis of DNA content in Hürthle cell adenomas and carcinomas of the thyroid. Am J Clin Pathol 89:764–769PubMedGoogle Scholar
  324. 324.
    Schark C, Fulton N, Yashiro T, et al (1992) The value of measurement of ras oncogenes and nuclear DNA analysis in the diagnosis of Hürthle cell tumors of the thyroid. World J Surg 16:745–751; discussion 752PubMedCrossRefGoogle Scholar
  325. 325.
    Bouras M, Bertholon J, Dutrieux-Berger N, Parvaz P, Paulin C, Revol A (1998) Variability of Ha-ras (codon 12) proto-oncogene mutations in diverse thyroid cancers. Eur J Endocrinol 139:209–216PubMedCrossRefGoogle Scholar
  326. 326.
    Maximo V, Soares P, Lima J, Cameselle-Teijeiro J, Sobrinho-Simoes M (2002) Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on Hürthle cell tumors. Am J Pathol 160:1857–1865PubMedGoogle Scholar
  327. 327.
    Variakojis D, Getz ML, Paloyan E, Straus FH (1975) Papillary clear cell carcinoma of the thyroid gland. Hum Pathol 6:384–390PubMedGoogle Scholar
  328. 328.
    Carcangiu ML, Sibley RK, Rosai J (1985) Clear cell change in primary thyroid tumors. A study of 38 cases. Am J Surg Pathol 9:705–722PubMedCrossRefGoogle Scholar
  329. 329.
    Lam KY, Lo CY (1998) Metastatic tumors of the thyroid gland: a study of 79 cases in Chinese patients. Arch Pathol Lab Med 122:37–41PubMedGoogle Scholar
  330. 330.
    Sakamoto A, Kasai N, Sugano H (1983) Poorly differentiated carcinoma of the thyroid. Cancer 52:1849–1855PubMedCrossRefGoogle Scholar
  331. 331.
    Carcangiu ML, Zampi G, Rosai J (1984) Poorly differentiated (“insular”) thyroid carcinoma. A reinterpretation of Langhans’ “wuchernde Struma.” Am J Surg Pathol 8:655–668PubMedCrossRefGoogle Scholar
  332. 332.
    Flynn SD, Forman BH, Stewart AF, Kinder BK (1988) Poorly differentiated (“insular”) carcinoma of the thyroid gland: an aggressive subset of differentiated thyroid neoplasms. Surgery 104:963–970PubMedGoogle Scholar
  333. 333.
    Palestini N, Papotti M, Durando R, Fortunato MA (1993) [Poorly differentiated “insular” carcinoma of the thyroid: long-term survival]. Minerva Chir 48:1301–1305PubMedGoogle Scholar
  334. 334.
    Nishida T, Katayama S, Tsujimoto M, Nakamura J, Matsuda H (1999) Clinicopathological significance of poorly differentiated thyroid carcinoma. Am J Surg Pathol 23:205–211PubMedCrossRefGoogle Scholar
  335. 335.
    Venkatesh YS, Ordonez NG, Schultz PN, Hickey RC, Goepfert H, Samaan NA (1990) Anaplastic carcinoma of the thyroid. A clinicopathologic study of 121 cases. Cancer 66:321–330PubMedCrossRefGoogle Scholar
  336. 336.
    Dumitriu L, Stefaneanu L, Tasca C (1984) The anaplastic transformation of differentiated thyroid carcinoma. An ultrastructural study. Endocrinologie 22:91–96PubMedGoogle Scholar
  337. 337.
    Chang TC, Liaw KY, Kuo SH, Chang CC, Chen FW (1989) Anaplastic thyroid carcinoma: review of 24 cases, with emphasis on cytodiagnosis and leukocytosis. Taiwan Yi Xue Hui Za Zhi 88:551–556PubMedGoogle Scholar
  338. 338.
    LiVolsi VA, Brooks JJ, Arendash-Durand B (1987) Anaplastic thyroid tumors. Immunohistology. Am J Clin Pathol 87:434–442PubMedGoogle Scholar
  339. 339.
    Berry B, MacFarlane J, Chan N (1990) Osteoclastomalike anaplastic carcinoma of the thyroid. Diagnosis by fine needle aspiration cytology. Acta Cytol 34:248–250PubMedGoogle Scholar
  340. 340.
    Wan SK, Chan JK, Tang SK (1996) Paucicellular variant of anaplastic thyroid carcinoma. A mimic of Riedel’s thyroiditis. Am J Clin Pathol 105:388–393PubMedGoogle Scholar
  341. 341.
    Giuffrida D, Attard M, Marasa L, et al (2000) Thyroid carcinosarcoma, a rare and aggressive histotype: a case report. Ann Oncol 11:1497–1499PubMedCrossRefGoogle Scholar
  342. 342.
    Donnell CA, Pollock WJ, Sybers WA (1987) Thyroid carcinosarcoma. Arch Pathol Lab Med 111:1169–1172PubMedGoogle Scholar
  343. 343.
    Miettinen M, Franssila KO (2000) Variable expression of keratins and nearly uniform lack of thyroid transcription factor 1 in thyroid anaplastic carcinoma. Hum Pathol 31:1139–1145PubMedCrossRefGoogle Scholar
  344. 344.
    Neri A, Aldovini D, Leonardi E, Giampiccolo M, Pedrolli C (1990) [Primary angiosarcoma of the thyroid gland. Presentation of a clinical case]. Recenti Prog Med 81:318–321PubMedGoogle Scholar
  345. 345.
    Tsugawa K, Koyanagi N, Nakanishi K, et al (1999) Leiomyosarcoma of the thyroid gland with rapid growth and tracheal obstruction: a partial thyroidectomy and tracheostomy using an ultrasonically activated scalpel can be safely performed with less bleeding. Eur J Med Res 4:483–487PubMedGoogle Scholar
  346. 346.
    Chan YF, Ma L, Boey JH, Yeung HY (1986) Angiosarcoma of the thyroid. An immunohistochemical and ultrastructural study of a case in a Chinese patient. Cancer 57:2381–2388PubMedCrossRefGoogle Scholar
  347. 347.
    Sahoo M, Bal CS, Bhatnagar D (2002) Primary squamouscell carcinoma of the thyroid gland: new evidence in support of follicular epithelial cell origin. Diagn Cytopathol 27:227–231PubMedCrossRefGoogle Scholar
  348. 348.
    Harach HR, Day ES, de Strizic NA (1986) Mucoepidermoid carcinoma of the thyroid. Report of a case with immunohistochemical studies. Medicina 46:213–216PubMedGoogle Scholar
  349. 349.
    Arezzo A, Patetta R, Ceppa P, Borgonovo G, Torre G, Mattioli FP (1998) Mucoepidermoid carcinoma of the thyroid gland arising from a papillary epithelial neoplasm. Am Surg 64:307–311PubMedGoogle Scholar
  350. 350.
    Wenig BM, Adair CF, Heffess CS (1995) Primary mucoepidermoid carcinoma of the thyroid gland: a report of six cases and a review of the literature of a follicular epithelial-derived tumor. Hum Pathol 26:1099–1108PubMedCrossRefGoogle Scholar
  351. 351.
    Chan JK, Albores-Saavedra J, Battifora H, Carcangiu ML, Rosai J (1991) Sclerosing mucoepidermoid thyroid carcinoma with eosinophilia. A distinctive low-grade malignancy arising from the metaplastic follicles of Hashimoto’s thyroiditis. Am J Surg Pathol 15:438–448PubMedGoogle Scholar
  352. 352.
    Chan JK, Rosai J (1991) Tumors of the neck showing thymic or related branchial pouch differentiation: a unifying concept. Hum Pathol 22:349–367PubMedCrossRefGoogle Scholar
  353. 353.
    Iwasa K, Imai MA, Noguchi M, et al (2002) Spindle epithelial tumor with thymus-like differentiation (SETTLE) of the thyroid. Head Neck 24:888–893PubMedCrossRefGoogle Scholar
  354. 354.
    Ahuja AT, Chan ES, Allen PW, Lau KY, King W, Metreweli C (1998) Carcinoma showing thymiclike differentiation (CASTLE tumor). AJNR Am J Neuroradiol 19:1225–1228PubMedGoogle Scholar
  355. 355.
    Bayer-Garner IB, Kozovska ME, Schwartz MR, Reed JA (2004) Carcinoma with thymus-like differentiation arising in the dermis of the head and neck. J Cutan Pathol 31:625–629PubMedCrossRefGoogle Scholar
  356. 356.
    Roka S, Kornek G, Schuller J, Ortmann E, Feichtinger J, Armbruster C (2004) Carcinoma showing thymic-like elements: a rare malignancy of the thyroid gland. Br J Surg 91:142–145PubMedCrossRefGoogle Scholar
  357. 357.
    Hazard JB, Hawk WA, Crile G (1959) Medullary (solid) carcinoma of the thyroid. A clinicopathologic entity. J Clin Endocrinol Metab 19:152–161PubMedCrossRefGoogle Scholar
  358. 358.
    Williams ED (1965) A review of 17 cases of carcinoma of the thyroid and pheochromocytoma. J Clin Pathol 18:288–292PubMedGoogle Scholar
  359. 359.
    Williams ED (1966) Histogenesis of medullary carcinoma of the thyroid. J Clin Pathol 19:114–118PubMedGoogle Scholar
  360. 360.
    Block MA, Horn RC, Miller JM, Barrett JL, Brush BE (1967) Familial medullary carcinoma of the thyroid. Ann Surg 166:403–412PubMedCrossRefGoogle Scholar
  361. 361.
    Albores-Saavedra J, LiVolsi VA, Williams ED (1985) Medullary carcinoma. Semin Diagn Pathol 2:137–146PubMedGoogle Scholar
  362. 362.
    Wolfe HJ, Melvin KE, Cervi-Skinner SJ, et al (1973) C-cell hyperplasia preceding medullary thyroid carcinoma. N Engl J Med 289:437–441PubMedCrossRefGoogle Scholar
  363. 363.
    Mulligan LM, Kwok JB, Healey CS, et al (1993) Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363:458–460PubMedCrossRefGoogle Scholar
  364. 364.
    Hofstra RM, Landsvater RM, Ceccherini I, et al (1994) A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma [see comments]. Nature 367:375–376PubMedCrossRefGoogle Scholar
  365. 365.
    Mulligan LM, Eng C, Healey CS, et al (1994) Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC. Nat Genet 6:70–74PubMedCrossRefGoogle Scholar
  366. 366.
    Uribe M, Fenoglio-Preiser CM, Grimes M, Feind C (1985) Medullary carcinoma of the thyroid gland. Clinical, pathological and immunohistochemical features with review of the literature. Am J Surg Pathol 9:577–594PubMedCrossRefGoogle Scholar
  367. 367.
    Wolfe HJ, Delellis RA (1981) Familial medullary thyroid carcinoma and C cell hyperplasia. Clin Endocrinol Metab 10:351–365PubMedCrossRefGoogle Scholar
  368. 368.
    Leboulleux S, Baudin E, Travagli JP, Schlumberger M (2004) Medullary thyroid carcinoma. Clin Endocrinol (Oxf) 61:299–310CrossRefGoogle Scholar
  369. 369.
    Williams E, Karim S, Sandler M (1968) Prostaglandin secretion by medullary carcinoma of the thyroid: a possible cause of the associated diarrhea. Lancet 1:22–23PubMedCrossRefGoogle Scholar
  370. 370.
    Kakudo K, Miyauchi A, Ogihara T, et al (1982) Medullary carcinoma of the thyroid with ectopic ACTH syndrome. Acta Pathol Jpn 32:793–800PubMedGoogle Scholar
  371. 371.
    Sipple JH (1961) The association of pheochromocytoma with carcinoma of the thyroid gland. Am J Med 31:163–166CrossRefGoogle Scholar
  372. 372.
    Jansson S, Hansson G, Salander H, Stenstrom G, Tisell L (1984) Prevalence of C-cell hyperplasia and medullary thyroid carcinoma in a consecutive series of pheochromocytoma patients. World J Surg 8:493–500PubMedCrossRefGoogle Scholar
  373. 373.
    Eng C (1996) RET proto-oncogene in multiple endocrine neoplasia type 2 and Hirschprung’s disease. Semin Med Beth Israel Hosp, Boston 335:943–951Google Scholar
  374. 374.
    Eng C (1999) RET proto-oncogene in the development of human cancer. J Clin Oncol 17:380–393PubMedGoogle Scholar
  375. 375.
    Eng C, Clayton D, Schuffenecker I, et al (1996) The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. JAMA 276:1575–1579PubMedCrossRefGoogle Scholar
  376. 376.
    Kebebew E, Ituarte PH, Siperstein AE, Duh QY, Clark OH (2000) Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems. Cancer 88:1139–1148PubMedCrossRefGoogle Scholar
  377. 377.
    Kambouris M, Jackson CE, Feldman GL (1996) Diagnosis of multiple endocrine neoplasia (MEN) 2A, 2B and familial medullary thyroid cancer (FMTC) by multiplex PCR and heteroduplex analyses of RET proto-oncogene mutations. Hum Mutat 8:64–70PubMedCrossRefGoogle Scholar
  378. 378.
    Nakata S, Okugi H, Saitoh Y, Takahashi H, Shimizu K (2001) Multiple endocrine neoplasia type 2B. Int J Urol 8:398–400PubMedCrossRefGoogle Scholar
  379. 379.
    Nguyen L, Niccoli-Sire P, Caron P, et al (2001) Pheochromocytoma in multiple endocrine neoplasia type 2: a prospective study. Eur J Endocrinol 144:37–44PubMedCrossRefGoogle Scholar
  380. 380.
    Marsh DJ, Zheng Z, Arnold A, et al (1997) Mutation analysis of glial cell line-derived neurotrophic factor, a ligand for an RET/coreceptor complex, in multiple endocrine neoplasia type 2 and sporadic neuroendocrine tumors. J Clin Endocrinol Metab 82:3025–3028PubMedCrossRefGoogle Scholar
  381. 381.
    Borrello MG, Smith DP, Pasini B, et al (1995) RET activation by germline MEN2A and MEN2B mutations. Oncogene 11:2419–2427PubMedGoogle Scholar
  382. 382.
    Eng C, Smith DP, Mulligan LM, et al (1994) Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours. Hum Mol Genet 3:237–241PubMedCrossRefGoogle Scholar
  383. 383.
    Cohen EG, Shaha AR, Rinaldo A, Devaney KO, Ferlito A (2004) Medullary thyroid carcinoma. Acta Otolaryngol 124:544–557PubMedCrossRefGoogle Scholar
  384. 384.
    Asa SL (1997) C-cell lesions of the thyroid. Pathol Case Rev 2:210–217Google Scholar
  385. 385.
    Abrosimov A (1996) [Histologic and immunohistochemical characterization of medullary thyroid carcinoma]. Arkh Patol 58:43–48Google Scholar
  386. 386.
    Alevizaki M, Dai K, Grigorakis SI, Legon S, Souvatzoglou A (1994) Amylin/islet amyloid polypeptide expression in medullary carcinoma of the thyroid: correlation with the expression of the related calcitonin/CGRP genes. Clin Endocrinol (Oxf) 41:21–26Google Scholar
  387. 387.
    Dominguez-Malagon H, Delgado-Chavez R, Torres-Najera M, Gould E, Albores-Saavedra J (1989) Oxyphil and squamous variants of medullary thyroid carcinoma. Cancer 63:1183–1188PubMedCrossRefGoogle Scholar
  388. 388.
    Harach HR, Williams ED (1983) Glandular (tubular and follicular) variants of medullary carcinoma of the thyroid. Histopathology 7:83–97PubMedGoogle Scholar
  389. 389.
    Huss LJ, Mendelsohn G (1990) Medullary carcinoma of the thyroid gland: an encapsulated variant resembling the hyalinizing trabecular (paraganglioma-like) adenoma of thyroid. Mod Pathol 3:581–585PubMedGoogle Scholar
  390. 390.
    Landon G, Ordonez NG (1985) Clear cell variant of medullary carcinoma of the thyroid. Hum Pathol 16:844PubMedCrossRefGoogle Scholar
  391. 391.
    Mendelsohn G, Baylin SB, Bigner SH, Wells SA, Jr., Eggleston JC (1980) Anaplastic variants of medullary thyroid carcinoma: a light-microscopic and immunohistochemical study. Am J Surg Pathol 4:333–341PubMedGoogle Scholar
  392. 392.
    Kos M, Separovic V, Sarcevic B (1995) Medullary carcinoma of the thyroid: histomorphological, histochemical and immunohistochemical analysis of twenty cases. Acta Med Croatica 49:195–199PubMedGoogle Scholar
  393. 393.
    DeLilles RA, Rule AH, Spiler F, et al (1978) Calcitonin and carcinoembryonic antigen as tumor markers in medullary thyroid carcinoma. Am J Clin Pathol 70:587Google Scholar
  394. 394.
    Hirsch MS, Faquin WC, Krane JF (2004) Thyroid transcription factor-1, but not p53, is helpful in distinguishing moderately differentiated neuroendocrine carcinoma of the larynx from medullary carcinoma of the thyroid. Mod Pathol 17:631–636PubMedCrossRefGoogle Scholar
  395. 395.
    Matsubayashi S, Yanaihara C, Ohkubo M, et al (1984) Gastrin-releasing peptide immunoreactivity in medullary thyroid carcinoma. Cancer 53:2472PubMedCrossRefGoogle Scholar
  396. 396.
    Roth KA, Bensch KG, Hoffman AR (1987) Characterization of opioid peptides in human thyroid medullary carcinoma. Cancer 59:1594PubMedCrossRefGoogle Scholar
  397. 397.
    Komminoth P, Roth J, Saremasiani P, et al (1994) Polysialic acid of the neural cell adhesion molecule in the human thyroid: a marker for medullary carcinoma and primary C-cell hyperplasia. An immunohistochemical study on 79 thyroid lesions. Am J Surg Pathol 18:399PubMedGoogle Scholar
  398. 398.
    Ruppert JM, Eggleston JC, deBustros A, Baylin SB (1986) Disseminated calcitonin-poor medullary thyroid carcinoma in a patient with calcitonin-rich primary tumor. Am J Surg Pathol 10:513–518PubMedCrossRefGoogle Scholar
  399. 399.
    Randolph GW, Maniar D (2000) Medullary carcinoma of the thyroid. Cancer Control 7:253–261PubMedGoogle Scholar
  400. 400.
    Giuffrida D, Ferrau F, Bordonaro R, et al (2000) [Medullary carcinoma of the thyroid: diagnosis and therapy]. Clin Ter 151:29–35PubMedGoogle Scholar
  401. 401.
    Gimm O, Sutter T, Dralle H (2001) Diagnosis and therapy of sporadic and familial medullary thyroid carcinoma. J Cancer Res Clin Oncol 127:156–165PubMedCrossRefGoogle Scholar
  402. 402.
    Gilliland FD, Hunt WC, Morris DM, Key CR (1997) Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973–1991. Cancer 79:564–573PubMedCrossRefGoogle Scholar
  403. 403.
    Randolph GW (1996) Medullary carcinoma of the thyroid: subtypes and current management. Compr Ther 22:203–210PubMedGoogle Scholar
  404. 404.
    Brierley J, Tsang R, Simpson WJ, Gospodarowicz M, Sutcliffe S, Panzarella T (1996) Medullary thyroid cancer: analyses of survival and prognostic factors and the role of radiation therapy in local control. Thyroid 6:305–310PubMedCrossRefGoogle Scholar
  405. 405.
    Schroder S, Bocker W, Baisch H, et al (1988) Prognostic factors in medullary thyroid carcinomas. Survival in relation to age, sex, stage, histology, immunocytochemistry, and DNA content. Cancer 61:806–816PubMedCrossRefGoogle Scholar
  406. 406.
    Albores-Saavedra J, Gorraez de la Mora T, de la Torre-Rendon F, Gould E (1990) Mixed medullary-papillary carcinoma of the thyroid: a previously unrecognized variant of thyroid carcinoma. Hum Pathol 21:1151–1155PubMedCrossRefGoogle Scholar
  407. 407.
    Giove E, Renzulli G, Lorusso C, Merlicco D, Iacobone D (2004) [Mixed medullary and follicular carcinoma of the thyroid: report of one case]. Ann Ital Chir 75:251–256; discussion 257PubMedGoogle Scholar
  408. 408.
    Kashima K, Yokoyama S, Inoue S, et al (1993) Mixed medullary and follicular carcinoma of the thyroid: report of two cases with an immunohistochemical study. Acta Pathol Jpn 43:428–433PubMedGoogle Scholar
  409. 409.
    LiVolsi VA (2004) Mixed follicular medullary thyroid carcinoma. Diagn Cytopathol 31:434; author reply 435CrossRefGoogle Scholar
  410. 410.
    Beressi N, Campos JM, Beressi JP, et al (1998) Sporadic medullary microcarcinoma of the thyroid: a retrospective analysis of eighty cases. Thyroid 8:1039–1044PubMedGoogle Scholar
  411. 411.
    Guyetant S, Dupre F, Bigorgne JC, et al (1999) Medullary thyroid microcarcinoma: a clinicopathologic retrospective study of 38 patients with no prior familial disease. Hum Pathol 30:957–963PubMedCrossRefGoogle Scholar
  412. 412.
    Albores-Saavedra JA, Krueger JE (2001) C-cell hyperplasia and medullary thyroid microcarcinoma. Endocr Pathol 12:365–377PubMedCrossRefGoogle Scholar
  413. 413.
    Kaserer K, Scheuba C, Neuhold N, et al (2001) Sporadic versus familial medullary thyroid microcarcinoma: a histopathologic study of 50 consecutive patients. Am J Surg Pathol 25:1245–1251PubMedCrossRefGoogle Scholar
  414. 414.
    Mizukami Y, Kurumaya H, Nonomura A, et al (1992) Sporadic medullary microcarcinoma of the thyroid. Histopathology 21:375–377PubMedGoogle Scholar
  415. 415.
    Sironi M, Cozzi L, Pareschi R, Spreafico GL, Assi A (1999) Occult sporadic medullary microcarcinoma with lymph node metastases. Diagn Cytopathol 21:203–206PubMedCrossRefGoogle Scholar
  416. 416.
    Russo F, Barone Adesi TL, Arturi A, et al (1997) [Clinicopathological study of microcarcinoma of the thyroid]. Minerva Chir 52:891–900PubMedGoogle Scholar
  417. 417.
    Yamauchi A, Tomita Y, Takakuwa T, et al (2002) Polymerase chain reaction-based clonality analysis in thyroid lymphoma. Int J Mol Med 10:113–117PubMedGoogle Scholar
  418. 418.
    Ghazanfar S, Quraishy MS, Essa K, Muzaffar S, Saeed MU, Sultan T (2002) Mucosa associated lymphoid tissue lymphoma (MALToma) in patients with cold nodule thyroid. J Pak Med Assoc 52:131–133PubMedGoogle Scholar
  419. 419.
    Takano T, Miyauchi A, Matsuzuka F, Yoshida H, Kuma K, Amino N (2000) Diagnosis of thyroid malignant lymphoma by reverse transcription-polymerase chain reaction detecting the monoclonality of immunoglobulin heavy chain messenger ribonucleic acid. J Clin Endocrinol Metab 85:671–675PubMedCrossRefGoogle Scholar
  420. 420.
    Diaz-Arias AA, Bickel JT, Loy TS, Croll GH, Puckett CL, Havey AD (1992) Follicular carcinoma with clear cell change arising in lingual thyroid. Oral Surg Oral Med Oral Pathol 74:206–211PubMedCrossRefGoogle Scholar
  421. 421.
    LiVolsi VA, Perzin KH, Savetsky L (1974) Carcinoma arising in median ectopic thyroid (including thyroglossal duct tissue). Cancer 34:1303–1315PubMedCrossRefGoogle Scholar
  422. 422.
    Doshi SV, Cruz RM, Hilsinger RL Jr (2001) Thyroglossal duct carcinoma: a large case series. Ann Otol Rhinol Laryngol 110:734–738PubMedGoogle Scholar
  423. 423.
    Cignarelli M, Ambrosi A, Marino A, Lamacchia O, Cincione R, Neri V (2002) Three cases of papillary carcinoma and three of adenoma in thyroglossal duct cysts: clinical-diagnostic comparison with benign thyroglossal duct cysts. J Endocrinol Invest 25:947–954PubMedGoogle Scholar
  424. 424.
    Fih J, Moore R (1963) Ectopic thyroid tissue and ectopic thyroid carcinoma. Ann Surg 157:212–222Google Scholar
  425. 425.
    Devaney K, Snyder R, Norris HJ, Tavassoli FA (1993) Proliferative and histologically malignant struma ovarii: a clinicopathologic study of 54 cases. Int J Gynecol Pathol 12:333–343PubMedGoogle Scholar
  426. 426.
    Kdous M, Hachicha R, Gamoudi A, et al (2003) [Struma ovarii. Analysis of a series of 7 cases and review of the literature]. Tunis Med 81:571–576PubMedGoogle Scholar
  427. 427.
    Rosenblum NG, LiVolsi VA, Edmonds PR, Mikuta JJ (1989) Malignant struma ovarii. Gynecol Oncol 32:224–227PubMedCrossRefGoogle Scholar
  428. 428.
    Koo HL, Jang J, Hong SJ, Shong Y, Gong G (2004) Renal cell carcinoma metastatic to follicular adenoma of the thyroid gland. A case report. Acta Cytol 48:64–68PubMedGoogle Scholar
  429. 429.
    Matias-Guiu X, LaGuette J, Puras-Gil AM, Rosai J (1997) Metastatic neuroendocrine tumors to the thyroid gland mimicking medullary carcinoma: a pathologic and immunohistochemical study of six cases. Am J Surg Pathol 21:754–762PubMedCrossRefGoogle Scholar
  430. 430.
    Baloch ZW, LiVolsi VA (1999) Tumor-to-tumor metastasis to follicular variant of papillary carcinoma of thyroid. Arch Pathol Lab Med 123:703–706PubMedGoogle Scholar
  431. 431.
    Bronner MP H R, LiVolsi VA (1994) Utility of frozen section analysis on follicular lesions of the thyroid. Endocr Pathol 5:154–161CrossRefGoogle Scholar
  432. 432.
    Paessler M, LiVolsi VA, Baloch Z (2001) Role of Ultrafast Papanicolaou stained scrape preparations as an adjunct to frozen section in the surgical management of thyroid lesions. Endocr Pract 7:89–94PubMedGoogle Scholar
  433. 433.
    Rodriguez JM, Parrilla P, Sola J, et al (1994) Comparison between preoperative cytology and intraoperative frozensection biopsy in the diagnosis of thyroid nodules. Br J Surg 81:1151–1154PubMedGoogle Scholar
  434. 434.
    Taneri F, Poyraz A, Tekin E, Ersoy E, Dursun A (1998) Accuracy and significance of fine-needle aspiration cytology and frozen section in thyroid surgery. Endocr Regul 32:187–191PubMedGoogle Scholar
  435. 435.
    Shaha AR, DiMaio T, Webber C, Jaffe BM (1990) Intraoperative decision making during thyroid surgery based on the results of preoperative needle biopsy and frozen section. Surgery 108:964–967; discussion 970–971PubMedGoogle Scholar
  436. 436.
    Shaha A, Gleich L, Di Maio T, Jaffe BM (1990) Accuracy and pitfalls of frozen section during thyroid surgery. J Surg Oncol 44:84–92PubMedCrossRefGoogle Scholar
  437. 437.
    Basolo F, Baloch ZW, Baldanzi A, Miccoli P, LiVolsi VA (1999) Usefulness of Ultrafast Papanicolaou-stained scrape preparations in intraoperative management of thyroid lesions. Mod Pathol 12:653–657PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2007

Authors and Affiliations

  • Zubair W. Baloch
    • 1
  • Virginia A. LiVolsi
    • 1
  1. 1.Department of Pathology and Laboratory MedicineUniversity of Pennsylvania Medical CenterPhiladelphiaUSA

Personalised recommendations